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ABSTRACT
TREATMENT PREDICTORS OF DIALECTICAL BEHAIVOR THERAPY AMONG
ADOLESCENT FEMALES IN RESIDENTIAL CARE
by
Taylor Davine
The University of Wisconsin-Milwaukee, 2020
Under the Supervision of Professor Han-joo Lee, Ph.D.
Dialectical Behavior Therapy (DBT) is a comprehensive intervention for the treatment of
borderline personality disorder (BPD), which is characterized by significant emotion
dysregulation and associated parasuicidal behaviors. Findings from 21 randomized-controlled
trials indicated that DBT is effective in the treatment of BPD symptoms. While effective, some
individuals do not obtain symptoms reductions after completing DBT. The aim of the current
study was to identify factors that predict treatment response among adolescent females (N = 107)
receiving DBT in a residential setting. It was hypothesized that residents with elevated scores of
emotion regulation difficulties, intolerance of uncertainty, experiential avoidance, social anxiety
symptoms, and PTSD-related symptoms would show less improvement of BPD symptoms. On
average, there were no significant predictors to response to DBT. The results showed that
irrespective of pre-treatment clinical predictors, DBT was effective, on average, in reducing
clinical outcome symptoms for approximately half of the sample: 55% of the residents showed
reliable change (RC) from pre-treatment to post-treatment, 41% showed no RC, and 3% showed
RC toward deterioration. Further, 22% of the residents in the current study showed clinically
significant change, meaning that their post-treatment outcome scores would indicate symptom
remission. None of the study predictors were able to predict whether a resident showed clinically

ii

significant change or no clinically significant change at post-treatment. Limitations and future
directions were discussed.
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Dialectical Behavior Therapy (DBT) is an evidenced-based cognitive behavioral
treatment that was originally developed to treat chronically suicidal women who were
unresponsive to standard cognitive-behavioral intervention (Linehan, Armstrong, Suarez,
Allmon, & Heard, 1991), and later evolved into a treatment for borderline personality disorder
(BPD; Linehan, 1993a; 1993b). The word dialectic refers to the belief that two opposing ideas
can be true at the same time, and a dialectic approach to therapy searchers for the synthesis
between opposite forces. For instance, DBT therapists are deliberate in their use of acceptance
(e.g., mindfulness, validation) and change (e.g., problem solving, cognitive restricting) strategies.
Empirical Support of DBT for BPD
To date there are at least 20 randomized controlled trials of DBT for BPD (see Linehan,
Dimeff, Koerner, & Miga, 2014) and several reviews (Bloom, Woodward, Susmaras, &
Pantalone, 2012; Lynch, Trost, Salsman, & Linehan, 2007; Panos, Jackson, Hasan, & Panos,
2014; Robins & Chapman, 2004). Together, the results are robust and provide strong support of
DBT as a treatment for BPD that reduces self-harm and suicide-related behaviors. DBT is
currently listed as an empirically supported treatment for BPD by Division 12 of the American
Psychological Association.
Support is also growing for the use of DBT to treat BPD and co-occurring psychiatric
disorders, including substance use disorder (DBT-SUD; Axelrod, Perepletchikova, Holtzman, &
Sinha, 2010; Dimeff & Linehan, 2008), eating disorders (Chen, Matthews, Allen, Kuo, &
Linehan, 2008; Lynch, et al., 2013; Palmer et al., 2003; Telsh, Agras, & Linehan, 2001), posttraumatic stress disorder (Harned & Linehan, 2008; Harned, Korslund, Foa, & Linehan, 2012;
Steil, Dyer, Priebe, Kleindienst, & Bohus, 2011), and transdiagnostic emotion regulation
(Neasciu, Eberle, Kramer, Wiesmann, & Linehan, 2014; Ritschel, Lim, & Stewart, 2015).
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Adolescent DBT
The effectiveness of DBT to treat adult population prompted the developed of DBT to
treat adolescents with BPD-like symptoms. DBT was adapted to treat adolescents (DBT-A;
Miller, Rathus, Linehan, Wetzler, & Leigh, 1997; Miller, 1999; Rathus & Miller, 2000) in the
following ways. First, the duration of DBT-A was shortened by reducing the number of DBT
skills. This was done in an effort to increase retention of adolescents in treatment and reduce
financial burden of treatment. There is no standardized length of time that DBT-A is completed;
although, a 16-week format has been proposed (Miller, Rathus, & Linehan, 2007). Second,
caregivers are asked to join DBT skills groups. Incorporating caregivers into skills group is
intended to reduce maladaptive environmental barriers (e.g., arguments, “invalidating
environment”). Third, the language and layout of DBT training materials (e.g., handouts, diary
cards) were simplified for DBT-A in consultation with Dr. Linehan. Fourth, DBT-A organized
DBT skills into five modules instead of four. The additional module is called Middle Path and
includes validation, dialectical thinking, and behavioral skills, which are part of the current “core
skills” of Interpersonal Effectiveness module of the adult manual. The Middle Path module is
aimed to help adolescents and their caregivers resolve conflict more effectively.
While there is some disagreement about diagnosing BPD in adolescents (Chanen &
McCutcheon, 2008), increasing evidence suggests that diagnosis of BPD in adolescents is as
reliable and valid as diagnosis of BPD in adults (Chanen, Jovev, McCutcheon, Jackson, &
McGorry, 2008; Kaess, Brunner & Chanen, 2014; Miller, Muehlenkamp, & Jacobson, 2008).
Irrespective of BPD diagnosis, among young people aged 15 to 24, suicide remains a major
health concern and was the second leading cause of death in 2016 with 5,723 deaths (Centers for
Disease Control; CDC), and suicidal ideation among youth has been reported in the range of
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19.8% and 24% (Cha et al., 2017; Nock et al., 2008). Trends of suicide-related behaviors and
deaths have increased since 2010, with the greatest increases among adolescent females
(Twenge, Joiner, Rogers, & Martin, 2018).
Research of DBT-A has grown significantly since the first trial of DBT-A was conducted,
and the data suggests that DBT-A is effective for treating BPD-like symptoms in adolescents
(MacPherson, Cheavens, & Fristad, 2013; McCredie, Quinn, & Covington, 2017). DBT-A has
been employed in different treatment settings, including inpatient hospitalization (Katz & Cox,
2002; McDonell et al., 2010; Swenson, Sanderson, Dulit, & Linehan, 2001), residential
hospitalization (McCredie et al., 2017; Wasser, Tyler, McIlhaney, Taplin, & Henderson, 2008),
partial hospitalization (Memel, 2012), and outpatient (James, Winmill, Anderson, & Alfoadari,
2011; Rathus & Miller, 2002; Woodberry & Popenoe, 2008). A review of DBT-A supports the
use of DBT-A in reducing BPD symptomatology, suicidal ideation and comorbid depression, and
hospitalizations for adolescents across treatment settings (Groves, Backer, van den Bosch, &
Miller, 2012).
Treatment Predictors of DBT
While the findings of DBT clinical trials are robust and show that DBT provides
significant symptom reductions, DBT does not work for all individuals (Rizvi, 2011), and 25%
or more of adults enrolled in a trial tend to drop out prematurely (Linehan et at. 2006; McMain et
al., 2009; Steuwe, Berg, Driessen, Beblo, 2017). Kröger, Harbeck, Armbrust, and Kliem (2013)
examined data from 1,423 individuals with BPD who were admitted to a 3-month inpatient unit
conducing DBT. They found that 45% of patients responded to DBT, 30.6% remained
unchanged, 11.0% deteriorated, and 10% dropped out, highlighting the need for research that
assesses idiographic outcome of individuals receiving DBT, and attention to treatment predictors
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of DBT may prove fruitful. Identification of treatment predictors of DBT can promote clinical
gains for individuals receiving DBT and providers delivering DBT. In turn, fewer resources may
be needed to obtain meaningful clinical outcome.
Several studies have been conducted to identify factors associated with premature
dropout of DBT and/or treatment response of DBT among adults. Factors associated with
premature DBT dropout included low education level (Perroud, Uher, Dieben, Nicastro, &
Huguelet, 2010), higher levels of baseline experiential avoidance, higher trait anxiety, fewer past
suicide attempts (Rüsch et al., 2008), a lack of motivation (Soler et al., 2008), substance use
disorder, younger age at pre-treatment (Kröger et al., 2013) childhood neglect (Steuwe, Berg,
Driessen, & Beblo, 2017), higher anger, poorer therapeutic alliance, higher number of life-time
suicide attempts, and greater Axis I comorbidity (Wnuk et al., 2013). Factors not associated with
premature DBT dropout include length of hospitalizations, severity of BPD symptoms, comorbid
diagnoses, and socio-economic status (Barnicot, Katsakou, Marougka, & Priebe, 2011). Factors
related to poor treatment response (as indicated by self-report measures) to DBT include schizoid
features, low narcissistic traits, a second course of treatment (Perroud et al., 2010), higher
baseline levels of depression, more emergency department visits, and higher unemployment
(McMain et al., 2017).
In summary, DBT is an effective treatment for adults and adolescents with BPD or BPDlike symptoms. DBT can be applied in different health care setting, and for different psychiatric
concerns. However, opportunity remains to increase the effectiveness of DBT, and more research
is needed to identify factors that contribute to treatment response.
Therefore, the current study investigated potential treatment predictors of DBT. The
following pre-treatment predictors of DBT outcome were selected based on theoretical support
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and clinical experience: (1) difficulty regulating emotions, (2) intolerance of uncertainty, (3),
experiential avoidance, (4) social anxiety symptoms, and (5) trauma symptoms.
Emotion dysregulation.
Thompson (1994) defined emotion regulation as ‘the extrinsic and intrinsic processes
responsible for monitoring, evaluating, and modifying emotional reactions, especially their
intensive and temporal features, to accomplish one’s goals.’ An inability to effectively regulate
emotions often leads to experiences of emotion dysregulation, which is a central feature across a
range of psychiatric symptoms including depression (Jormann & Gotlib, 2010), anxiety (Mennin,
Heimberg, Turk, & Fresco, 2002), PTSD (Tull, Barrett, McMillan, & Roemer, 2007), substance
use (Fox, Axelrod, Paliwal, Sleeper, & Sinha, 2007), and nonsuicidal self-injury (Gratz and
Roemer, 2008; McKenzie & Gross, 2013). Emotion dysregulation is also core to
conceptualizations of BPD (Glenn & Klonsky, 2009), including Linehan’s biosocial model of
BPD (1993a). Linehan’s model posits that BPD symptoms arise from a transaction between a
biological vulnerability of the emotion regulation system (high emotional sensitivity, high
emotional reactivity, and slow return to emotional baseline) and an invalidating environment.
DBT skills are aimed to increase one’s ability to regulate emotions, thus reducing BPD
symptoms. While emotion dysregulation is a target of DBT and a likely mechanism of change
(Gratz, Levy, & Tull, 2012), it is unclear how pre-treatment levels of emotion regulation
difficulties affect DBT outcome.
Intolerance of uncertainty.
Intolerance of uncertainty is characterized by significant distress resulting from
ambiguity of a future event that has the possibility of a negative outcome regardless of the
probability. Intolerance of uncertainty has received the most research attention in the area of
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generalized anxiety disorder and obsessive-compulsive disorder (Dugas, Gosselin, & Ladouceur,
2001; Wilhelm & Steketee, 2006). However, there is growing evidence in adult populations that
intolerance of uncertainty is a transdiagnostic feature across multiple disorders (Boswell,
Thompson-Hollands, Farchione, & Barlow, 2013; Carleton et al., 2012; Gentes & Ruscio, 2011),
including depression (Yook, Kim, Suh, & Lee, 2010), social anxiety (Boelen & Reijntjes, 2009;
Carleton, Collimore, & Asmundson, 2010), eating disorders (Sternheim, Startup, & Schmidt,
2011), and serves as a mechanism of change (McEvoy & Mahoney, 2012). Research of
adolescents also supports a strong relationship between intolerance of uncertainty and anxiety
symptoms, including anxiety sensitivity and health anxiety (Wright, Adams, Lebell, & Carleton,
2016).
Because intolerance of uncertainty is present in many disorders that are characterized by
negative affect, it is likely present among individuals with BPD who show high comorbidity with
disorders of negative affect (Grant et al, 2008). Research of intolerance of uncertainty within the
context of DBT is important. Given that DBT is a behavioral treatment that requires individuals
to learn and apply new skills, individuals higher in intolerance of uncertainty may not engage in
treatment as much as someone lower in intolerance of uncertainty, thus hindering beneficial
outcome. However, there is no known research that has examined the effect of intolerance of
uncertainty as a treatment predictor of DBT.
Experiential avoidance.
Experiential avoidance is characterized by a broad range of maladaptive behaviors that
individuals use to avoid distressing experiences. Hayes and colleagues (2004, p. 554) describe
experiential avoidance as “a phenomenon that occurs when a person is unwilling to remain in
contact with particular private experiences (e.g., bodily sensations, emotions, thoughts,
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memories, images, behavioral predispositions) and takes steps to alter the form or frequency of
these experiences or the contexts that occasion them, even when these forms of avoidance cause
behavioral harm.” In BPD, experiential avoidance is associated with BPD symptoms including
deliberate self-harm, which often functions to avoid negative emotions (Chapman, Gratz, &
Brown, 2006; Hulbert & Thomas, 2010; Rosenthal et al., 2005).
Many of the DBT skills require an individual to experience difficult emotions and
sensations in order to replace ineffective coping strategies (e.g., dissociation, self-harm, selfinvalidation) with more effective coping strategies (e.g., mindfulness, distress tolerance).
Avoidance of internal experiences may be a barrier to fully engaging in treatment, potentially
hindering treatment effects. Rüsch and colleagues (2008) found that among 60 adult women
receiving inpatient DBT, premature dropout was associated with higher levels of experiential
avoidance than lower levels among completers than non-completers. Experiential avoidance is
also associated with less improvement of depressive symptoms over psychological treatment
(Berking, Neacsiu, Comtois, & Linehan, 2009). To date, it appears that no published studies have
examined the association between EA and treatment outcomes for adolescents with BPD. To
further our understanding of role of experiential avoidance in DBT, it is important to examine the
relationship between experiential avoidance on BPD symptoms.
Co-occurring psychiatric symptoms.
Social anxiety symptoms.
Social anxiety disorder is characterized by a significant fear and avoidance of social
interactions where evaluation (generally negative) is possible. Individuals with social anxiety
symptoms may fear specific situations (e.g., public speaking, attending a party) or most
situations in general. These symptoms can manifest cognitively (e.g., distorted beliefs of one’s
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self) and behaviorally (e.g., avoidance). These symptoms, when present among DBT clients may
be problematic given that DBT skills are taught in a group setting, thus potentially limiting skills
acquisition and generalization.
People who report social anxiety symptoms (without BPD symptoms) are more likely to
benefit from treatment for social-anxiety symptoms when the therapy is conducted individually
rather than in group settings (Stangier, Heidenreich, Peitz, Lauterbach, and Clark 2003). Dimeff,
Rizvi, Brown, and Linehan (2000) conducted a pilot study to test the efficacy of DBT in treating
with co-morbid BPD and methamphetamine -dependence. They reported that one-third of the
sample met criteria for social anxiety disorder, and these individuals did not respond as well to
treatment compared to individuals without social anxiety disorder. Dimeff and colleagues (2000)
found success in treating social anxiety symptoms prior to individuals starting DBT skills group.
Trauma symptoms.
Many individuals with BPD experience co-occurring post-traumatic stress disorder
(PTSD). Grant et al. (2008) reported from a large-scale epidemiological survey that 47.2% of
women with BPD had comorbid PTSD. This is not surprising given that trauma history (e.g.,
sexual abuse, physical abuse) is a strong predictor of self-harm behaviors (see review, Lang &
Sharma-Patel, 2011) and was proposed to have a causal relationship to BPD (Ball & Links,
2009). Comorbid BPD and PTSD significantly increases the rate of suicide attempts, with two to
five times more likely than BPD or PTSD alone (Pagura et al., 2010). The high prevalence of
BPD and PTSD prompted the development a prolonged exposure protocol for comorbid BPD
and PTSD (DBT-PE; Harned et al., 2012), and the findings are promising.
Research (not specific to DBT) of the role of trauma symptoms is not well understood in
the treatment outcome literature and more research is needed. Some evidence suggests that a
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history of sexual trauma is a moderator of treatment outcome for PTSD (Markowitz, Neria,
Lovell, Meter, & Petkova, 2017). Markowitz and colleagues (2017) found that interpersonal
psychotherapy, prolonged exposure, and relaxation therapy were all efficacious in reducing
PTSD symptoms, individuals with a sexual trauma history responded better to interpersonal
therapy than prolonged exposure or relaxation therapy. However, another study does not show
sexual trauma as a moderator of treatment outcome (Diamond, Creed, Gillham, Gallop, &
Hamilton, 2012). The disparate findings may be accounted for by treatment type and population.
Markowitz and colleagues (2017) tested Prolonged Exposure (PE; Foa & Rothbaum, 1998),
Interpersonal Psychotherapy (IPT; Markowitz, 2016), and Progressive Relaxation (PR; Jacobsen,
1938) for adults with PTSD, while Diamond and colleagues (2012) tested Attachment-based
Family Therapy (ABFT; Diamond, Reis, Diamond, Siqueland, & Isaacs, 2002) for suicidal
adolescents with sexual trauma history. These findings highlight the need for further research of
the effects of pre-existing PTSD-symptoms on treatment outcome.
The proposed study is important for several reasons. First, it provides researchers and
clinicians with a better understanding of factors that predict treatment response of DBT. This
information can guide treatment adaptations that may increase treatment effectiveness for DBT
clients. Second, this information can guide how an organization (e.g., psychiatric hospital)
implements DBT. Third, the results can guide future adaptations and iterations of DBT. For
instance, DBT-skills protocols have been developed for co-occurring BPD and substance use
disorder (DBT-SUDS; Linehan, 2014), PTSD (DBT-PE; Harned, Korslund, Foa, & Linehan,
2012), and binge eating disorder (DBT-BED; Telch, Agras, & Linehan, 2001).
Hypotheses
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The aim of the proposed study was to identify treatment predictors of DBT among
adolescent patients in a residential treatment program. There were five hypotheses of the
proposed study.
1. As residents’ level of emotion dysregulation difficulties increased at pre-treatment (DER36 scores), they would show less change of BPD symptoms at post-treatment.
2. As residents’ level of social-anxiety symptoms increased at pre-treatment (BFNE scores),
they would show less change of BPD symptoms at post-treatment.
3. As residents’ level of PTSD symptoms increased at pre-treatment (PCL-5 scores), they
would show less change of BPD symptoms at post-treatment.
4. As residents’ level of intolerance of uncertainty increased at pre-treatment (IUSC scores),
they would show less change of BPD symptoms at post-treatment.
5. As residents’ level of experiential avoidance increased at pre-treatment (AAQ-II), they
would show less change of BPD symptoms at post-treatment.
Method
Data Collection Procedures
Adolescent females (N = 107) aged 13 to 18 (mean age = 15.88, SD = .96) who were
admitted to a residential program with significant emotion dysregulation and/or self-harm
urges/actions and suicidal ideation. During the admission process, residents provided informed
assent and their parents provide informed consent to allow data to be used for research purposes.
Residents and their parents completed a battery of questionnaires that included demographic
information, medical history, and clinical measures. All clinical measures administered at pretreatment were administered again at post-treatment. The current study was approved by the
institutional review board (IRB) of the psychiatric hospital.
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Adolescent DBT program
To ensure the fidelity of DBT, the psychiatric hospital employed a DBT consultant who
was certified by Behavioral Tech (a Linehan-founded organization) to aid in program
development and implementation.
DBT-skills training for residents.
Clients in the residential program received group-based DBT-A skills training five days
per week, with a different module taught each day: Mondays = Core Mindfulness; Tuesdays =
Distress Tolerance; Wednesdays = Emotion Regulation; Thursdays = Interpersonal
Effectiveness, and Fridays = Middle Path. The schedule was developed to ensure that all skills
are taught at least twice prior to discharge. Clients also received weekly individual therapy,
medication management, and adjunctive activities (e.g., art therapy, experiential therapy,
outings). DBT skill use was reinforced by the milieu.
DBT-A includes five core modules: Mindfulness, Distress Tolerance, Emotion
Regulation, Interpersonal Effectiveness, and Walking the Middle Path. Mindfulness skills teach
clients to consciously bring awareness to the present moment without judgment. For instance,
clients are taught how to bring awareness to the breath and how to non-judgmentally observe
thoughts and behaviors. Distress Tolerance skills provide clients with ways to cope in the shortterm that are more effective than engaging in self-harm behaviors. The primary goal of Distress
Tolerance skills is help manage difficult situations without making them worse. Emotion
Regulation skills provide clients with an in-depth understanding of emotions and their associated
responses. Clients learn how to mitigate and/or prevent negative emotions with these skills.
Interpersonal Effectiveness skills help clients achieve interpersonal goals including effectively
asking for or denying a request, preserving a relationship, and maintaining self-respect. Walking
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the Middle Path skills help parents and adolescents to better understand each other’s perspective,
which can deescalate volatile situations and promote effective resolution. Validation strategies
are emphasized in this module. Skills-based phone coaching, therapist consultation team, and
phone coaching are included with comprehensive DBT-A. Skill use and generalization is an
important aspect of DBT. It was shown to fully mediate the likelihood of suicide attempts,
depression, and anger control, and partially mediated the likelihood of non-suicidal self-injury
(Neacsiu, Eberle, Kramer, Wiesmann, & Linehan, 2014).
Measures
Treatment predictors.
Emotional dysregulation.
The Difficulties in Emotion Regulation Scale (DERS-36; Gratz & Roemer, 2004) is a 36item self-report measure that assesses emotion regulation across six factors (Goals, Clarity,
Strategies, Impulse, Awareness, and Nonacceptance). The DERS-36 was designed to measure a
broad range of relevant difficulties of emotion regulation as described by several theories of
emotion regulation. Factor analysis supported a six-factor structure of the measure. Factor 1
(Nonacceptance) reflects a tendency to reject/not accept one’s own emotional distress. Factor 2
(Goals) is characterized by inhibited goal attainment when experiencing negative emotions.
Factor 3 (Impulse) indicated difficulties inhibiting maladaptive action urges when emotionally
distressed. Factor 4 (Awareness) reflects a lack of attention or awareness of emotional responses.
Factor 5 (Strategies) represents one’s belief that little can be done to regulate difficult emotions.
Factor 6 (Clarity) taps into the extent to which an individual can accurately identify experienced
emotions. The DERS Total score has demonstrated high internal consistency (α = .93), construct
validity, predictive validity, and preliminary test-retest reliability. There is also empirical support
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for the use of the DERS with adolescent populations (Neumann, van Lier, Gratz, & Koot, 2010;
Perez, Venta, Garnaat, & Sharp, 2012; Weinberg & Klonsky, 2009). The DERS contains items
that are rated on a 5-point Likert-type scale: 1 (almost never), 2 (sometimes), 3 (about half the
time), 4 (most of the time), and 5 (almost always). Several items are reversed scored. The total
score range is from 36 to 180 with higher scores indicative of greater emotion regulation
difficulties. Internal consistency within the current sample was high (α = .87).
Social anxiety symptoms.
The Brief Fear of Negative Evaluation Scale (BFNE; Leary, 1983) is 13-tiem self-report
measure that assesses one’s tolerance of the possibility they will be judged negatively in social
situations. The BFNE assesses the degree to which an individual experiences apprehension
toward the prospect of being evaluated negatively. Items are rated on a 5-point scale: 1 (not at all
characteristic of me), 2 (slightly characteristic of me), 3 (moderately characteristic of me), 4
(very characteristic of me), and 5 (extremely characteristic of me). Total scores range from 13 to
65, with higher scores indicating a greater degree of fear of negative evaluation than lower
scores. The BFNE has shown excellent internal consistency (α = .90) and high test-retest
reliability (r = .68) after four weeks (Leary, 1983). Internal consistency within the current sample
was acceptable (α = .65).
Trauma symptoms.
The PTSD Checklist for DSM-5 (PCL-5; Blevins, Weathers, Davis, Witte, & Domino,
2015) is a 20-item self-report measure that assess key features of PTSD. The PCL probes PTSD
symptoms experienced within the past month on a scale from 1 (not at all) to 5 (extremely). Total
scores range from 17 to 85, and cut-off scores are interpretations are provided: 17-29 (little to no
severity), 30-44 (moderate to moderately high severity), 45-85 (high severity). In a non-clinical
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sample, the PCL-C total score demonstrated excellent internal consistency (α = .94), high testretest correlations coefficients after one-week (r = .92) and two-weeks (r = .68), and evidence of
convergent validity (Ruggiero, Del Ben, Scotti, & Rabalais, 2003). Internal consistency within
the current sample was excellent (α = .94).
Intolerance of uncertainty.
The Intolerance of Uncertainty Scale for Children (IUSC; Comer et al., 2009) is a 27item measure that assess children’s (aged 7 to 17) level of negative reactivity to ambiguous
situations. The IUSC was adapted from the adult version of the intolerance of uncertainty scale
(Buhr & Dugas, 2002). Respondents rate each item on a 5-point Likert-type scale which three
anchor points: 1 (not at all), 3 (somewhat), and 5 (very much). Total scores range from 27 to 135.
The IUSC has demonstrated strong internal consistency (α = .92) and convergent validity
(Comer et al., 2009). Internal consistency within the current sample was excellent (α = .94).
Experiential avoidance.
The Acceptance and Action Questionnaire-II (AAQ-II; Bond et al., 2011) is a 7-item selfreport measure that assesses experiential avoidance and cognitive inflexibility. The AAQ-II was
adapted from the original Acceptance and Action Questionnaire (AAQ; Hayes et al., 2004). Each
item is rated on a 7-point scale from 1 (never true) to 7 (always true). Items 1, 6, and 10 are
reverse scored. The total score range is from 7 to 49, and lower scores indicate greater levels of
experiential avoidance. The AAQ-II has shown strong psychometric properties across six
independent samples. The mean internal consistency across samples was good (α = .84), testretest reliability after 3-months and 12-months was high (r = .81 and r = .79, respectively), and
convergent and incremental validity was supported. Internal consistency within the current
sample was good (α = .86).
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Primary outcome measure.
DBT aims to reduce borderline symptoms. Thus, the primary outcome measure for the
current study is the Borderline Symptom List (Bohus et al., 2009), a validated measure that is
listed as an assessment instrument for use in DBT research by the Linehan Institute.
The Borderline Symptom List short-version (BSL-23; Bohus et al., 2009) is a briefer
version of the original BSL with 95 items (Bohus et al., 2007). The BSL-95 was developed to
assess symptoms of BPD according to DSM-IV-TR criteria. Clinical experts and clients with
BPD were also interviewed. The BSL-23 was developed to provide a valid measure of BPD
symptoms with less respondent burden than the BSL-95. The items selected for the BSL-23
showed the greatest sensitivity to change and the largest discriminant validity when identifying
individual with and without BPD. Across multiple samples, the BSL-23 showed large
correlations with the BSL-95, rs > .95), excellent internal consistency (α = .93), and a strong
discriminant validity (mean effect size = 1.13). Internal consistency within the current sample
was excellent (α = .90).
Secondary outcome measures.
Secondary outcome measures were selected to assess improvements in other important
areas of life, including depressive symptoms and quality and satisfaction with life.
The Quick Inventory of Depressive Symptomatology (QIDS-SR; Rush et al., 2003).
The QIDS-SR is a 16-item self-report measure that was developed to assess DSM-IV
symptom criterion domains of depression (e.g., mood, sleep, suicidal ideation). The QIDS-SR
has high internal consistency (α = .86), high convergent and concurrent validity, and is sensitive
to change. Items are rated on a 0 to 3 scale, with no standardized anchor points. Not all item
scores are included in the total score (see scoring instructions), and that total score range is 0 to
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27. High scores represent greater severity than lower scores. Internal consistency within the
current sample was excellent (α = .99).
The Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q;
Endicott, Nee, Yang, & Wohlberg, 2006).
The PQ-LES-Q is a 15-item self-report measure that assesses a broad range of life aspects
relevant to children and adolescents. Across three independent samples, the PQ-LES-Q
demonstrated good internal consistency (alphas ranged = .87 to .90) and test-retest reliability
(screening to baseline = .78). Items are rated from 1 to 5 (“very poor,” “poor,” “fair,” “good,”
and “very good,” respectively). The first 14 items are summed to form a total score ranging from
14 to 70, with higher scores representing greater enjoyment and satisfaction. Internal
consistency within the current sample was excellent (α = .99).
Data Analytic Plan
Methodological Consideration for Primary Outcome Indices: Residual change
scores.
Linear regression analyses were conducted to test the study hypotheses. There is,
however, discussion about how to best assess outcome in the literature. It is common for
researchers to employ simple change (gain) scores to assess intervention effects. Simple change
scores are calculated by subtracting Time 2 scores from Time 1 scores (e.g., depression before
intervention was 60, after intervention it was 20; thus, there was a decrease of 40 points in
depression). This method of assessing treatment effects has drawn controversy in the literature
with some advocating that they can be useful under certain conditions (Castro-Schilo & Grimm,
2018; Gottman & Rusche, 1993; Rogosa & Willett, 1983; Williams, & Zimmerman (1996),
while others argue that simple change scores provide spurious findings (Cattell, 1983).
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Cronbach and Furby (1970) highlighted a common concern with simple changes scores, that
subtracting pretest scores from posttest scores leads to erroneous conclusions due to random
error of the measurement. For instance, obtaining “observed” data at two time points results in an
amalgam of measurement error that may indicate “true” change when in fact it is not. Rather,
inferred “true” change may merely represent the measurement error at two time points. Another
issue with simple change scores is regression to the mean (Barnett, van der Pols, & Dobson,
2005). That is, observing atypically high/low scores during one observation will be observed less
during subsequent observations as scores trend toward the “true” score (i.e., mean score). This is
problem is highlighted by Adams, Houle, Parker, and Burkee (2012) who examined changes to
depressive symptoms during substance abuse treatment. They found that participants showed
significant improvements in symptoms reductions; however, further analyses indicated
regression to the mean accounted for some of the observed change.
Residual change scores were computed in SPSS by conducting a simple linear regression
with post-treatment outcome scores (e.g., BSL-23) regressed onto pre-treatment outcomes scores
with ‘standardized’ residuals saved. Data points that fall below the regression slope produce
negative residual change scores, which indicate that a resident showed more symptom reductions
at post-treatment than would be expected after controlling for pre-treatment scores (see Figure
1). Values that fall above the regression line produce positive residual change scores, which
indicate that there were less symptom reductions than would be expected after controlling for
pre-treatment scores. Therefore, residual change scores can index the magnitude of symptom
change while taking into consideration the baseline level of symptom severity. The primary
outcome measure was residual change scores of the BSL-23. Secondary outcome indices were
residual change scores of the QIDS and PQ-LES-Q.
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Reliable change, reliable change index, and clinically significant change.
Assessing symptom changes from pre-treatment to post-treatment is essential to clinical
research. Yet, many studies rely on examining between-group symptom changes, and this grouplevel of analysis does not allow researchers to draw conclusions about individual changes.
Barlow and Nock (2009) proposed that an individual is the primary unit of analysis in the
psychological sciences.
This goal of assessing ideographic phenomena can be partially achieved with a statistical
approach developed by Jacobson and Truax (1991) called reliable change (RC) and the reliable
change index (RCI). RC represents the amount of change (or difference between pre-treatment
and post-treatment) in SD units rather than simple change scores. Unless there is equal change
among individuals, each individual will have a different RC score. Given the use of SD units to
assess change, an RC greater than 1.96 (2 SDs) indicates a statistically reliable change (beyond
what would be expected from measurement error alone). RCI represents the absolute value of the
difference score (which is computed based on the reliability and variability information of the
particular measure) needed to determine whether observed changes were statistically reliable and
not a function of measurement error.
Once it is established that observed changes are statistically reliable, the next step is to
assess whether the changes are clinically meaningful. That is, has clinically significant change
(CSC) occurred to extent than an individual moved from an affected group (BPD) to an
unaffected group (Normal Control)? CSC can also be used to assess whether an individual
deteriorated during an intervention. Jacobson, Follette, and Revenstorf (1984) provided the
following definition of clinical significance: “a change in therapy is clinically significant when
the client moves from the dysfunctional to the functional range during the course of therapy”
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(p.340). This definition of clinical significance is predicated on the assumption that the “normal”
or “functional” range of the population is known. Normative data were available from the
psychometric study of the original BSL with 95 items (Bohus et al., 2007).
To calculate the RC, RCI and CSC, there are several pieces of information that are
needed including, pre- and post-treatment scores, SD of measure, reliability of the measure
(preferably test-retest or internal consistency), and a cutoff score or reported means of affected
and unaffected samples of the outcome measure to establish a CSC threshold.
Procedures for establishing reliable change and reliable change index.
1. Calculate standard error of measurement (SEM = s√1-rxx)
a. s = SD of reference group
b. rxx = reliability of the instrument (test-retest or Chronbach’s alpha)
2. Calculate SDiff = √2(SEM2)
a. SDiff = SD of the errors of measurement of the difference scores
3. Calculate the difference score for each individual
a. Diff = MeanT1 – MeanT2
4. RC = (MeanT1 – MeanT2)/SDiff
a. RC > 1.96 = reliable change (an individual’s standardized score)
5. RCI = (1.96)*SDiff
a. The RCI for the BSL-23 was (1.96)*(.46) = .89 for the current study. Thus, any
resident with a difference score greater than the absolute threshold of .89 was
considered to show statistically reliable change.
Clinically Significant Change: BSL-23 Cutoff Score.
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A cutoff score was calculated according to recommendations of Jacobson and Truax
(1991) who proposed three different methods for calculating a cutoff point (methods: a, b, and c)
that indicates a resident moved from the “dysfunctional” distribution to the “normal”
distribution.
Cutoff score method ‘a’ is recommended when data from a “normal” distribution is
unknown. Cutoff score ‘a’ is calculated by using the “dysfunctional” distribution mean and
moving two SDs in the direction of the “normal” distribution (i.e., symptom reductions).
Jacobson and Truax (1991) posited that cutoff score ‘a’ will be too conservative when the
distributions overlap, as is the case of the psychometric data provided by Bohus and colleagues
(2007) that showed that individuals with BPD (n = 308) had a BSL-95 mean score of 2.0 (SD =
.76) and healthy controls (n = 204) had a BSL-95 mean score of 0.4 (SD = .22). Cutoff score ‘b’
represents the mean of the “normal” distribution plus 2*SD of the pre-treatment scores. Cutoff
score ‘b’ is relatively lenient relative to ‘a’ and ‘c’ and equaled .84 in the current study. Cutoff
score ‘c’ represents the mid-point between the “dysfunctional” and “normal” distributions. Using
the Jacobson and Truax (1991) formula to calculate cutoff score ‘c,’ mean BSL-23 score at posttreatment equaled .77 in the current study. This was problematic, given that the mean of the
“dysfunctional” distribution was 2.0 and SD was .76 (Bohus et al., 2007). Thus, using cutoff
score ‘c’ according to Jacobson and Truax would be too lenient in the current sample, with the
CSC threshold approximately half of a SD away rather than the two SD recommendations.
Given that cutoff scores computed with ‘b’ and ‘c’ did not make theoretical sense given
the obtained cutoff scores, method ‘a’ was employed, which is justified considering that the
obtained CSC cutoff score of the current study was .48, which is closer to the “normal”
distribution mean of .44 reported by Bohus and colleagues (2007) than cutoff ‘b’ (.84) or ‘c’
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(.77). Cutoff score ‘a’ was the most conservative of the three and selected to protect against Type
I error. Residents who met the RC and RCI threshold were classified as CSC if their mean BSL23 score was .48 or lower at post-treatment; Resident were classified as no CSC if they met the
RC and RCI threshold but not the cutoff score. Finally, residents were classified as deteriorated
if they met the RC and RCI threshold in the opposite direction (i.e., increased borderline
symptoms). See Figure 2 for illustration.
Results
Study Hypotheses
Do emotion dysregulation symptoms at pre-treatment predict symptom change on BSL23?
Simple-linear regressions were conducted to test the hypotheses that residents with
greater DERS-36 scores at pre-treatment would show less reductions of borderline symptoms,
depressive symptoms, and poorer quality of life than residents with lower DERS-36 scores at
pre-treatment. The hypotheses were not supported, see Table 2. Pre-treatment DERS-36 scores
did not predict residual change of BSL-23scores, F(1, 89) = .01, b = .01, t = .09, p = .93.
Additionally, DERS-36 scores did not predict QIDS, F(1, 89) = .72, b = -.09, t = -.85, R2 <.01, p
= .40, or PQ-LES-Q, F(1, 89) = 1.19, b = .12, t = 1.09, R2 = .01, p = .28, residual change scores.
Do social anxiety symptoms at pre-treatment predict symptom change on BSL-23?
Due to the low sample size of the BFNE responses (n = 10), there was not enough
statistical power to detect a significant effect. Nevertheless, the analyses were conducted to
provide preliminary data on the association between pre-treatment BFNE scores and outcome by
examing effect sizes (i.e., R2). Three separate simple-linear regressions were conducted to test
the hypotheses that residents with increased BFNE scores at pre-treatment would show less
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reductions of borderline symptoms, depressive symptoms, and poorer quality of life. The
hypotheses were not supported, see Table 2. Pre-treatment BFNE scores did not predict residual
change of BSL-23 scores, F(1, 9) = .01, b = .01, t = -.02 p = .95, R2 < .01. Additionally, BFNE
scores did not predict QIDS, F(1, 9) = .20, b = .15, t = -.85, R2 = .02, p = .66, or PQ-LES-Q, F(1,
19) = .13, b = .08, t = .36, R2 < .01, p = .72, residual change scores. Only 2% of the variance in
residual change of BSL-23 was account for by pre-treatment BFNE scores, and less than 1%
variance was accounted in residual change of QIDS and PQ-LES-Q.
Do PTSD symptoms at pre-treatment predict symptom change on BSL-23?
Three separate simple-linear regressions were conducted to test the hypotheses that
residents with increased PCL-5 scores at pre-treatment would show less reductions of borderline
symptoms, depressive symptoms, and poorer quality of life than residents with lower PCL-5
scores at pre-treatment. The hypotheses were not supported, see Table 2. Pre-treatment PCL-5
scores did not predict residual change of BSL-23 scores, F(1,19) = .05, b = .05, t = .23, R2 < .01,
p = .82. Additionally, PCL-5 scores did not predict QIDS, F(1, 19) = .01, b = .02, t = .08, R2 <
.01, p = .94, or PQ-LES-Q, F(1, 19) = .13, b = .08, t = .36, R2 < .01, p = .72, residual change
scores.
Does level of intolerance of uncertainty at pre-treatment predict symptom change on
BSL-23?
Three separate simple-linear regressions were conducted to test the hypotheses that
residents with increased IUSC scores at pre-treatment would show less reductions of borderline
symptoms, depressive symptoms, and poorer quality of life than residents with lower IUSC
scores at pre-treatment. The hypotheses were not supported, see Table 2. Pre-treatment IUSC
scores did not predict residual change of IUSC scores, F(1, 89) = 2.98, b = .18, t = 1.73, R2= .03,
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p = .09. Additionally, IUSC scores did not predict QIDS, F(1, 89) = .97, b = .12, t = 1.16, R2
=.02, p = .25, or PQ-LES-Q, F(1, 89) = 1.88, b = -.14, t = -.14, R2 = .02, p = .17, residual change
scores.
Does Level of Experiential Avoidance at Pre-treatment Predict Symptom Change on
BSL-23?
Due to the low sample size of the AAQ-II responses (n = 6), there was not enough
statistical power to detect a significant effect. Nevertheless, the analyses were conducted to
provide preliminary data on the association of AAQ-II and outcome by examing effect sizes (i.e.,
R2). Three separate simple-linear regressions were conducted to test the hypotheses that residents
with increased AAQ-II scores at pre-treatment would show less reductions of borderline
symptoms, depressive symptoms, and poorer quality of life.. Three separate simple-linear
regressions were conducted to test the hypotheses that residents with increased AAQ-II scores at
pre-treatment would show less reductions of borderline symptoms, depressive symptoms, and
poorer quality of life.. The hypotheses were not supported, see Table 2. Pre-treatment AAQ-II
scores did not predict residual change of AAQ-II scores, F(1, 5) = 2.89, b = .61, t = 1.70, R2 =
37, p = .15. Additionally, AAQ-II scores did not predict QIDS, F(1, 5) = 1.37, b = .46, t = 1.17,
R2 = .22 p = .30, or PQ-LES-Q, F(1, 5) = 2.28, b = .56, t = -1.51, R2 = .31, p = .19, residual
change scores. Power for the current regression was not sufficient; however, the effects sizes
were small to medium, and the slopes suggest that as AAQ-II scores increase at pre-treatment,
residents were more likely to show more BSL-23 reductions than expected. This trend is in the
direction of the study hypothesis.
Secondary Data Analyses
Reliable Change, Reliable Change Index, and Clinically Significant Change.
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An RC score was computed for each resident on the BSL-23 (see Data Analytic Plan).
Resident were classified as (RC = 1, No RC = 0). Results of the classification revealed that 51 of
92 (55%) of the residents showed reliable change on the BSL-23 from pre- to post-treatment.
Next, the RCI was computed (RCI absolute threshold = .89) to determine the direction of the
reliable change by classification (RC = 1, No RC = 0, Deteriorated = -1). Results of the
classification revealed that 51 of 92 (55%) of the residents showed RC, 38 of 92 (41%) showed
no RC, and 3 of 92 (3%) showed RC toward deterioration. Finally, CSC classification was done
by assessing residents who met the RC/RCI threshold and whose BSL-23 post-treatment score
was below the cutoff score (mean = .44). Of the 51 residents who met the RCI threshold, 22 were
considered CSC, meaning that 27% showed enough improvement on the BSL-23 that they would
likely fall within the “normal” distribution. Sixty-seven of the residents (73%) showed RCI but
not CSC, and 3 of the 92 residents (3%) showed CSC toward deterioration. Table 3 provides RC,
RCI, and CSC status for each of the residents in the analysis.
Do pre-treatment clinical symptom scores predict clinically significant change?
Binary logistic regressions were conducted to test the extent to which pre-treatment
clinical scores (e.g., DERS-36, AAQ-II) predicted a resident’s group classification at posttreatment: 1 = clinically significant change (CSC) or 0 = no clinically significant change (No
CSC; see Table 4). Those who deteriorated were classified as No CSC for purposes of the
analyses.
The DERS-36 Total score at pre-treatment was not a significant predictor of group
classification, B = .01, SE = .01, Wald = 1.33, p = .25, Exp(B) = 1.01, Cox & Snell R2 = .02. For
every one-unit increase in DERS-36 Total score at pre-treatment, there was a 1.01 increased
chance that the resident would be classified into the CSC group. A secondary analysis of the six-
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factor subscales of the DERS-36 at pre-treatment revealed that they were not significant
predictors of group classification (ps ranged = .11 to .99). Awareness was approaching
significance, p = .11, Exp(B) = 1.11, trending in the direction of a 1.11 increased chance of being
classified as CSC for every one-unit increase in Awareness at pre-treatment.
Social anxiety symptoms at pre-treatment did not predict group classification, B = .03, SE
= .13, Wald = .05, p = .83, Exp(B) = 1.03, Cox & Snell R2 = <.01. However, the analysis was
underpowered (n = 7). The data trend reflected a 1.03 increase chance of being classified in the
CSC group for every one-unit increase in BFNE score at pre-treatment.
Trauma symptoms at pre-treatment did not predict group classification, B = .02, SE = .13,
Wald = .65, p = .42, Exp(B) = 1.02, Cox & Snell R2 = .03. This analysis was also underpowered
(n = 8). The data trend reflected a 1.02 increase chance of being classified in the CSC group for
every one-unit increase in PCL-5 pre-treatment score.
Experiential avoidance symptoms at pre-treatment did not predict group classification, B
= -0.13, SE = .12, Wald = 1.10, p = .29, Exp(B) = .88, Cox & Snell R2 = .18. The analysis was
underpowered (n = 4); however, the results trended in the opposite direction of the study
hypothesis. For every one-unit increase in AAQ-II score at pre-treatment, there was a 1.12
decreased chance of being classified as CSC.
Intolerance of uncertainty was not a significant predictor of group classification, B = -.01,
SE = .01, Wald = .19, p = .66, Exp(B) = 1.00, Cox & Snell R2 <.01. See Table 5 for a summary of
the results.
Discussion
While DBT is an effective treatment for adults and adolescents with BPD and BPD-like
features, it is not effective for all individuals (Kröger et al., 2013; Rizvi, 2011). Thus, there are
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opportunities for researchers to identify ways to increase treatment response. This line of
research can help improve outcome for individuals receiving DBT, reduce the amount of
resources needed to provide the treatment (e.g., shorter intervention duration), and inform ways
to adapt future DBT protocol iterations.
Thus, the aim of the current study was to test the extent to which pre-treatment factors
predicted response to DBT among adolescent females in residential care. We predicted that as
residents’ clinical symptom scores increased at pre-treatment, they would show less symptom
reductions than residents with decreased baseline clinical symptoms. Independent linear
regression analyses did not support the study hypotheses. While there were symptom
improvements across most measures from pre-treatment to post-treatment, no predictive
variables accounted for a significant amount of variance in residual change scores of the BSL-23,
QIDS, or PQ-LES-Q.
Neither difficulty in emotion regulation or intolerance of uncertainty scores at pretreatment were significant predictors of residual change of outcome. While the ability to
regulation one’s emotions is a proposed mechanism of change in BPD symptom (Gratz et al.,
2012), the current results suggest that emotion regulation difficulties at pre-treatment do not
interfere with treatment response. Intolerance of uncertainty has not been studied within the
context of BPD and treatment response. McEvoy and Mahoney (2012) posited that intolerance of
uncertainty is a mechanism of change across several psychiatric disorders, particularly those
associated with negative affect. The current study was first to assess the relationship between
pre-treatment intolerance of uncertainty severity and treatment outcome. The study hypothesis
was not supported, pre-treatment intolerance of uncertainty did not predict residual change of
outcome measures. Given the highly structured environment of residential settings, it is possible
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that uncertainty levels decrease quickly; thus, limiting the extent to which it affects treatment
response.
There was an inadequate sample size to analyze three of the study predictor measures
(i.e., AAQ-II, BFNE, and PCL-5); thus, interpretations of these results should be taken with
caution and serve to provide preliminary data and trends. The results indicated that level of pretreatment experiential avoidance was not a significant predictor of residual outcome in the
current study, which is counter to the results of Perroud and colleagues (2010) and Rüsch and
colleagues (2008) who found that individuals with higher levels of pre-treatment experiential
avoidance were associated with higher levels of premature dropout than individuals with lower
levels of pre-treatment experience avoidance. Of note, Perroud and colleagues (2010) assessed
response from an outpatient sample, and both Perroud and colleagues and Rüsch and colleagues
(2008) assessed treatment dropout rather than symptom reductions. Social anxiety symptoms
were also not a significant treatment predictor, which is inconsistent with the findings of Dimeff
and colleagues (2000) who that social anxiety interfered with response to DBT among
individuals with comorbid BPD and substance use disorder. There are two important distinctions
between the study by Dimmeff and colleagues (2010) and the current study. First, the current
study was conducted in a residential setting where residents cohabitate with each other 24-hour
per day rather than an outpatient setting (Dimeff et al., 2010) where contact between individuals
is generally once per week for two to three hours per interaction. Second, substance use disorder
was not a treatment target of the current study and, in fact, was a rule out for admission.
Together, these differences in social contexts and profile of psychiatric comorbidity may have
contributed to the divergent findings between the studies. Pre-treatment trauma symptoms did
not predict residual outcome. Interestingly, across residents, there were reductions of trauma
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symptoms from pre-treatment to post-treatment; however, trauma symptoms were not a target of
DBT among this resident population who were considered Stage 1 DBT clients (i.e., those with
active self-harm urges/action and suicidal ideation). Again, the analysis was underpowered.
Preliminary results suggest that core DBT skills may reduce PTSD symptoms, even when not a
target of treatment however, the mechanism of change remains unclear.
Secondary analyses assessing individual-level analyses (i.e., RC, RCI, CSC) showed that
23% of the current sample showed CSC, 72% showed no CSC, and 3% deteriorated. While these
values are lower than the response rates of reported by Kröger and colleagues (2013; CSC =
45%, no CSC = 30.6%, deterioration = 11%, premature dropout = 10%), these authors calculated
a CSC threshold of .80 which is more liberal than the .40 CSC threshold of the current study.
Additionally, Kröger and colleagues (2013) sample was older (mean age = 32.0, SD =10.27)
than the mean age of the current sample (mean age = 15.88, SD = .96).
Overall, the results trended in the direction that higher clinical symptom scores at pretreatment were predictive of greater residual change on outcome. While these trends are counter
to the current hypotheses, they suggest that DBT in residential settings is robust against pretreatment clinical symptoms and is effective for treating those with a range of pre-treatment
clinical severity. Further, the disparate findings can also be attributed to methodological
differences, particularly the way in which outcome was assessed among most treatment-outcome
studies (simple change scores) compared to the current study (residual change scores). Simple
change scores are affected by ceiling and floor effects (i.e., regression to the mean).
A possible explanation for the non-significant effects of pre-treatment clinical symptoms
on outcome can be attributed to the ‘high dose’ of DBT that residents receive. For instance, each
resident attended up to three DBT skills groups per day, five days per week. Additionally, they
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received individual therapy sessions, family sessions (to intervene in the environment), and
DBT-skills generalization group. Line therapists (residential counselors and behavior specialists)
were also trained in DBT and reinforced effective skill use, while blocking or redirecting
residents who were dysregulated and not effectively using skills. The ‘high dose’ of DBT
received in a residential setting is vastly different than outpatient settings where adolescents
attend a 2-hour skills group and a 1-hour individual session per week. Another possible
explanation is that DBT is a comprehensive treatment that effectively addresses multiple clinical
features characterized by emotion dysregulation difficulties (e.g., social anxiety, experiential
avoidance). Indeed, recent research suggests that DBT skills can be applied for transdiagnostic
emotion dysregulation difficulties (Neacsiu et al., 2014; Ritschel, 2015). Therefore, an individual’s
clinical presentation at pre-treatment may not be as important in residential settings as it may be
in other treatment settings.
Importantly, the CSC rate of the current study (22%) was low. While Kröger and
colleagues (2013) found a CSC rate of 45% among an inpatient sample, as mentioned before,
their cutoff score (.8) was more liberal than the cutoff score (.4) of the current study.
Additionally, their sample included adults rather than adolescents. Further, it has been noted that
residential programs are not designed specifically to reduce symptoms to a level of remission.
Instead, residential programs are tasked with the goal of reducing acute harm and providing an
environment for stabilization to occur (Whittaker et al., 2016). After discharge, residents often
take a step-down approach in treatment, with some residents continuing with partial
hospitalization program (PHP), intensive outpatient program (IOP), or general outpatient
(Garrison & Daigler, 2006).
Feasibility Limitations
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There were several limitations to the current study. First, there were barriers to the feasibility
of conducting a treatment outcome study within a large medical setting; thus, a feasibility
analysis is provided below. Second, the current study was not a randomized controlled trial, so
there was no comparison group to assess similarities and difference between the current sample.
So, although the aim of current study was to assess treatment predictors, inferences of treatment
efficacy are limited. Additionally, comparison of CSC rates at post-treatment without a similarly
representative pre-treatment control group limit interpretation. Third, the sample consisted of
female adolescents in a residential setting; thus, the generalizability of the results to other
populations is limited. Fourth, obtaining data at multiple time points throughout treatment (e.g.,
weekly) would provide a greater understanding of the idiographic patterns of treatment response.
For instance, if a resident showed elevated intolerance of uncertainty at pre-treatment, weekly
assessment would help to flesh out how these symptoms progress (increase, decrease, remain
unchanged) during the course of treatment. Finally, the exploratory nature of this study and large
number of analyses relative to sample size increases the likelihood of Type I error; thus, the
findings are preliminary and in need of further investigation.
Feasibility Analysis.
The primary purpose of a feasibility analysis is to ensure that an objective (e.g., research,
treatment implementation) can be done effectively. Bowen and colleagues (2009) posited eight
areas to focus on when considering feasibility research. Three areas (Implementation,
Practicality, and Integration) are particularly relevant for barriers experienced in the current
study. Implementation is the area that focuses on the extent to which an objective can be
implemented as planned. Practicality focuses on whether an objective can be completed when
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resources are constrained in some way. Integration addresses the level of system change needed
to integrate a new objective.
In the current study, there were several barriers to data collection including changes to the
planned data collection procedures, implementation of formal IRB procedures, and lower rates of
assent/consent for study enrollment than expected. The current study was conducted in a large
psychiatric hospital system whose primary aim is to deliver high-quality clinical services. As
such, there were limited research resources (Practicality) and IRB protocols (Implementation).
Recently, the organization increased its focus to collect clinical data for research purposes
(Integration), but with some systematic challenges.
The hospital has seen a rapid expansion, locally and nationally. This growth strains existing
resources, including the availability of those who maintain and process data. Further, there were
procedural changes to obtaining the de-identified data from the organization, which made it
difficult to obtain data for analyses. It is unclear how procedural changes were communicated
(e.g., electronic communication, scheduled trainings) to units within the organization.
Recommendations for Future Research in Community Settings.
Pilot studies.
Prior to data collection, a pilot study should be conducted to evaluate whether data collection
procedures were implemented as intended. McHugh and Barlow (2010) defined implementation
as “the process of transferring the treatment to the clinical setting (e.g., training).” A pilot study
will increase the likelihood that an intervention or objective (e.g., data collection) can be
administered and completed with high fidelity, which in turn will protect against threats to
internal validity. A pilot study will also ensure that implementing new protocols can be
completed given the current resources of an organization (Damschroder et al., 2009). Finally, a
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pilot study is often short-term; thus, if there are challenges integrating an objective, changes can
be made or terminated with minimal impact to the organization.
In retrospect, if the current study was pilot tested, the research investigators would have been
involved, or have communication with, relevant departments who administer the organizational
protocols such as screening, recruitment, retention, treatment adherence, treatment fidelity, and
assessment (Leon, Davis, & Kraemer, 2011).
Effective collaboration with IRBs across multiple organizations.
The IRB is tasked with ensuring that research of animals and humans is conducted ethically,
with minimal harm, and with benefit to populations being examined (Schneider, 2013). While
precedent has been set for IRB guidelines and standards, there remains variability across
organizations in IRB procedures (Shore et al., 2011). Given these differences in IRB procedures,
it is important for researchers to remain in regular contact with involved IRBs across
organizations. In the current study, IRB procedures and which organization to defer to was
unclear. Further complicating IRB approval were changes to the IRB procedures among one of
the organizations that implemented a formal IRB procedure after data collection for the current
study began. Thus, regular communication between the study investigators and organization’s
IRB may have decreased the barriers to data collection. Additionally, it would ensure that
involved organizations and research investigators have a shared definition and clear guidelines
for executing a study. It was unclear how the organization that implemented a formal IRB during
active data collection communicated changes to relevant parties.
Proactive communication between departments to ensure data collection fidelity and
accessibility.
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In the current study, data was collected and shared between different organizations. This was
challenging given that access to data for analyses was delayed (sometimes up to several weeks).
Additionally, different organizations had different infrastructure (e.g., software), and different
procedures for collecting, deidentifying, and storing data. Therefore, research investigators
should have a procedure (e.g., monthly communication) with each department involved in the
study protocol to ensure that data is being collected as intended and accessible when needed.
This will ensure that any unknown/uncommunicated changes in protocols can be identified prior
to the completion of data collection.
Assent and consent.
Clinical data in real-world settings is needed to affirm that interventions developed under
tightly controlled conditions translate into real-world results. This can be challenging when
conducting research with vulnerable populations, including minors under the age of 18.
Researchers have an ethically duty to ensure that minors and their parents understand the scope
of the study and their rights as participates to make an informed decision.
Obtaining assent of child/adolescent to participate in research, in addition to their
parent/guardian, poses challenges given their vulnerable status. Vitielllo (2003) described assent
as a clear agreement to participate, rather than the absence of objection. Among individuals
admitted into the residential program of the current study, approximately 75% of the
residents/families assented/consented to use data for research purposes. It is unclear whether this
was a function of refusal or lack of obtaining written documentation.
Improving assent/consent procedures may increase enrollment rates. Dockett, Perry and
Kearney (2011) developed assent and information forms for minors, with the aim of promoting
discussion about research enrollment. Their qualitative study revealed that minors valued being
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asked to make decisions about their own participation in research, and they found information on
the forms helpful. Many of these forms have been developed from research that sought advice
from minors in the development of information packages (Connors & Stalker, 2007; Jones,
2004). Institutions may benefit from an increase in enrollment of research when using innovative
approaches to obtaining assent/consent. Thus, an organization should adopt the spirit of
evidence-based assessment and treatment so that they can design their measures in a way that
contributes to research mission.
Conclusions
The current study was the first to examine the extent to which pre-treatment clinical
symptoms predicted borderline symptom residual change among adolescent females receiving
DBT in a residential setting. Despite the relatively low sample size, which suggests results
should be interpreted with caution and more research needed, the results of the current study
provided preliminary evidence that further supports the use of DBT to treat adolescents with
emotional dysregulation and BPD-like symptoms within a higher level of care. On average,
residents showed reductions of symptoms across clinical measures from pre- to post-treatment.
Further, most residents (55%) showed RC in the direction of improvement and 24% showed
CSC. Importantly, the findings from the current study suggest that DBT delivered in a residential
setting is robust against pre-treatment symptom severity as pre-treatment clinical scores across
several disorder-related measures did not predict treatment response.

34

References
Adams, C. E., Houle, T. T., Parker, J. D., & Burke, R. S. (2012). Examining changes in
depressive symptoms during substance abuse treatment in the context of regression to the
mean. Addictive Disorders & Their Treatment, 11(4), 183-194.
Axelrod, S. R., Perepletchikova, F., Holtzman, K., & Sinha, R. (2011). Emotion
regulation and substance use frequency in women with substance dependence and
borderline personality disorder receiving dialectical behavior therapy. The American
Journal of Drug and Alcohol Abuse, 37(1), 37-42.
Ball, J. S., & Links, P. S. (2009). Borderline personality disorder and childhood trauma: evidence
for a causal relationship. Current Psychiatry Reports, 11(1), 63-68.
Barlow, D. H., & Nock, M. K. (2009). Why can't we be more idiographic in our research?
Perspectives on Psychological Science, 4(1), 19-21.
Barnicot, K., Gonzalez, R., McCabe, R., & Priebe, S. (2016). Skills use and common treatment
processes in dialectical behaviour therapy for borderline personality disorder. Journal of
Behavior Therapy and Experimental Psychiatry, 52, 147-156.
Barnicot K, Katsakou C, Marougka S, Priebe S. (2011). Treatment completion in psychotherapy
for borderline personality disorder – a systematic review and meta-analysis. Acta
Psychiatry Scandanavia, 123, 327-338.
Barnett, A. G., van der Pols, J. C., & Dobson, A. J. (2005). Regression to the mean: What it is
and how to deal with it. International Journal of Epidemiology, 34(1), 215–220
Bedics, J., Atkins, D. C., Harned, M., Linehan, M. M. (2015). The therapeutic alliance as a
predictor of outcome in dialectical behavior therapy versus nonbehavioral psychotherapy
by experts for borderline personality disorder. Psychotherapy, 52(1), 67-77.

35

Berking, M., Neacsiu, A., Comtois, K. A., & Linehan, M. M. (2009). The impact of experiential
avoidance on the reduction of depression in treatment for borderline personality disorder.
Behaviour Research and Therapy, 47(8), 663-670.
Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015). The
posttraumatic stress disorder checklist for DSM‐5 (PCL‐5): Development and initial
psychometric evaluation. Journal of Traumatic Stress, 28(6), 489-498.
Bloom, J. M., Woodward, E. N., Susmaras, T., & Pantalone, D. W. (2012). Use of dialectical
behavior therapy in inpatient treatment of borderline personality disorder: A systematic
review. Psychiatric Services, 63(9), 881-888.
Boelen, P. A., & Reijntjes, A. (2009). Intolerance of uncertainty and social anxiety. Journal of
Bohus, M., Haaf, B., Simms, T., Limberger, M. F., Schmahl, C., Unckel, C., . . . Linehan,
M. M. (2004). Effectiveness of inpatient dialectical behavioral therapy for borderline
personality disorder: a controlled trial. Behaviour Research and Therapy, 42(5), 487-499.
Anxiety Disorders, 23(1), 130-135.
Bohus, M., Kleindienst, N., Limberger, M. F., Stieglitz, R. D., Domsalla, M., Chapman, A. L., ...
& Wolf, M. (2009). The short version of the Borderline Symptom List (BSL-23):
development and initial data on psychometric properties. Psychopathology, 42(1), 32-39.
Bohus M., Limberger, M. F., Frank, U., Chapman, A. L., Kuehler, T., & Stieglitz, R. D. (2007).
Psychometric properties of the Borderline Symptom List (BSL). Psychopathology, 40,
126-132.
Bond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., ... & Zettle,

36

R. D. (2011). Preliminary psychometric properties of the Acceptance and Action
Questionnaire–II: A revised measure of psychological inflexibility and experiential
avoidance. Behavior Therapy, 42(4), 676-688.
Boswell, J. F., Thompson‐Hollands, J., Farchione, T. J., & Barlow, D. H. (2013). Intolerance of
uncertainty: A common factor in the treatment of emotional disorders. Journal of Clinical
Psychology, 69(6), 630-645.
Bornovalova, M. A., Levy, R., Gratz, K. L., & Lejuez, C. W. (2010). Understanding the
heterogeneity of BPD symptoms through latent class analysis: Initial results and clinical
correlated among inner-city substance users. Psychological Assessment, 22(2), 233-245.
Bowen, D. J., Kreuter, M., Spring, B., Cofta-Woerpel, L., Linnan, L., Weiner, D., … Fernandez,
M. (2009). How we design feasibility studies. American Journal of Preventive Medicine,
36(5), 452–457.
Buhr, K., & Dugas, M. J. (2002). The intolerance of uncertainty scale: Psychometric properties
of the English version. Behaviour Research and Therapy, 40(8), 931-945.
Burleson, J. A., & Kaminer, Y. (2005). Self-efficacy as a predictor of treatment outcome in
adolescent substance use disorders. Addictive Behaviors, 30(9), 1751-1764.
Castro-Schilo, L, & Grimm, K. J. (2018). Using residualized change versus difference scores for
longitudinal research. Journal of Social and Personal Relationships, 35(1), 32-58.
Carleton, R. N., Collimore, K. C., & Asmundson, G. J. (2007). Social anxiety and fear of
negative evaluation: Construct validity of the BFNE-II. Journal of Anxiety Disorders,
21(1), 131-141.
Carleton, R. N., Collimore, K. C., & Asmundson, G. J. G. (2010). It’s not just the judgments –

37

It’s that I don’t know: Intolerance of uncertainty as a predictor of social anxiety. Journal
of Anxiety Disorders, 24, 189-195.
Carleton, R. N., Mulvogue, M. K., Thibodeau, M. A., McCabe, R. E., Antony, M. M., &
Asmundson, G. J. (2012). Increasingly certain about uncertainty: Intolerance of
uncertainty across anxiety and depression. Journal of Anxiety Disorders, 26(3), 468-479.
Carter, G. L., Willcox, C. H., Lewin, T. J., Conrad, A. M., & Bendit, N. (2010). Hunter
DBT project: Randomized controlled trial of dialectical behaviour therapy in women with
borderline personality disorder. Australian & New Zealand Journal of Psychiatry, 44(2),
162-173.
Cha, C.B., Tezanos, K.M., Peros, O.M., Ng, M.Y., Ribeiro, J.D., Nock, M.K., & Franklin, J.C.
(2017). Accounting for diversity in suicide research: Sampling and sample reporting
practices in the United States. Suicide and Life-Threatening Behavior. Advanced online
publication. https://doi.org/10.1111/sltb.12344.
Chanen, A. M., & McCutcheon, L. K. (2008). Personality disorder in adolescence: The diagnosis
that dare not speak its name. Pers Ment Health, 2(1), 35–41.
Chapman, A. L., Gratz, K. L., & Brown, M. Z. (2006). Solving the puzzle of deliberate selfharm: The experiential avoidance model. Behaviour Research and Therapy, 44, 371-394.
Chawla, N., & Ostafin, B. (2007). Experiential avoidance as a functional dimensional approach
to psychopathology: An empirical review. Journal of clinical psychology, 63(9), 871-890.
Chen, E. Y., Matthews, L., Allen, C., Kuo, J. R., & Linehan, M. M. (2008). Dialectical behavior
therapy for clients with binge-eating disorder or bulimia nervosa and borderline
personality disorder. International Journal of Eating Disorders, 41(6), 505-512.
Chanen, A. M., Jovev, M., McCutcheon, L. K., Jackson, H. J., & McGorry, P. D. (2008).

38

Borderline personality disorder in young people and the prospects for prevention and
early intervention. Current Psychiatry Reviews, 4(1), 48-57.
Cohen, J. (1977). Statistical power analysis for the behavioral sciences. Routledge.
Comer, J. S., Roy, A. K., Furr, J. M., Gotimer, K., Beidas, R. S., Dugas, M. J., & Kendall, P. C.
(2009). The intolerance of uncertainty scale for children: A psychometric evaluation.
Psychological Assessment, 21(3), 402-411.
Connors, C., & Stalker, K. (2007). Children’s experiences of disability: Pointers to a social
model of childhood disability. Disability and Society, 22(1), 19–33.
Cronbach, L. J., & Furby, L. (1970). How should we measure “change”—or should we?
Psychological Bulletin, 74, 68–80.
Damschroder, L. J., Aron, D. C., Rosalind, K. E., Kirsh, S. R., Alexander, J. A., & Lowery, J.
(2009). Fostering implementation of health services research findings into practice: A
consolidated framework for advancing implementation science. Implementation Science,
4(1), 50.
Diamond, G., Creed, T., Gillham, J., Gallop, R., & Hamilton, J. L. (2012). Sexual trauma history
does not moderate treatment outcome in attachment-based family therapy (ABFT) for
adolescents with suicide ideation. Journal of Family Psychology, 26(4), 595.
Diamond, G. S., Reis, B. F., Diamond, G. M., Siqueland, L., & Isaacs, L. (2002). Attachmentbased family therapy for depressed adolescents: A treatment development study. Journal
of the American Academy of Child & Adolescent Psychiatry, 41(10), 1190-1196.Dimeff,
Dimeff, L. A., & Linehan, M. M. (2008). Dialectical behavior therapy for substance abusers.
Addiction Science & Clinical Practice, 4(2), 39–47.
Dimeff, L., Rizvi, S. L., Brown, M., & Linehan, M. M. (2000). Dialectical behavior therapy for

39

substance abuse: A pilot application to methamphetamine-dependent women with
borderline personality disorder. Cognitive and Behavioral Practice, 7(4), 457-468.
Dockett, S., Perry, Bl., & Kearney, E. (2013). Promoting children’s informed assent in research
participation. International Journal of Qualitative Studies in Education, 26(7), 802-828,
Dugas, M. J., Buhr, K., & Ladouceur, R. (2004). The role of intolerance of uncertainty in the
etiology and maintenance of generalized anxiety disorder. In: R. G. Heimberg, C. L.
Turk, & D. S. Mennin (Eds.), Generalized anxiety disorder: advances in research and
practice (pp. 143–163). New York: Guilford Press.
Dugas, M. J., Gosselin, P., & Ladouceur, R. (2001). Intolerance of uncertainty and worry:
Investigating specificity in a nonclinical sample. Cognitive Therapy and Research, 25(5),
551-558.
Endicott, J., Nee, J., Yang, R., & Wohlberg, C. (2006). Pediatric quality of life enjoyment and
satisfaction questionnaire (PQ-LES-Q): reliability and validity. Journal of the American
Academy of Child & Adolescent Psychiatry, 45(4), 401-407.
Faul, F., Erdfelder, E., Lang, A., & Buchner, A. (2007). G*Power 3: A flexible statistical power
analysis program for the social, behavioral, and biomedical sciences. Behavior Research
Methods, 39(2), 175-191.
Foa, E. B., & Rothbaum, B. O. (1998). Treating the trauma of rape: Cognitive behavioral
therapy for PTSD. New York: Guilford Press.
Fox, H. C., Axelrod, S. R., Paliwal, P., Sleeper, J., & Sinha, R. (2007). Difficulties in emotion
regulation and impulse control during cocaine abstinence. Drug and Alcohol
Dependence, 89(2-3), 298-301.
Garrison, D., & Daigler, G. (2006). Treatment settings for adolescent psychiatric conditions.

40

Adolescent Medicine Clinics, 17(1), 233.
Gentes, E. L., & Ruscio, A. M. (2011). A meta-analysis of the relation of intolerance of
uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and
obsessive–compulsive disorder. Clinical Psychology Review, 31(6), 923-933.
Glenn, C. R., & Klonsky, E. D. (2009). Emotion dysregulation as a core feature of borderline
personality disorder. Journal of Personality Disorders, 23(1).
Gottman, J. M., & Rushe, R. H. (1993). The analysis of change: Issues, fallacies, and new ideas.
Journal of Consulting and Clinical Psychology, 61, 907–910.
Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., … Ruan, W. J.
(2008). Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline
Personality Disorder: Results from the Wave 2 National Epidemiologic Survey on
Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 69(4), 533–545.
Gratz, K. L., Levy, R., & Tull, M. T. (2012). Emotion regulation as a mechanism of change in an
acceptance-based emotion regulation group therapy for deliberate self-harm among
women with borderline personality pathology. Journal of Cognitive Psychotherapy,
26(4), 365.
Gratz, K. L., & Roemer, L. (2004). Multidimensional assessment of emotion regulation and
dysregulation: Development, factor structure, and initial validation of the Difficulties in
Emotion Regulation Scale. Journal of Psychopathology and Behavioral Assessment,
26(1), 41-54.
Groves, S. Backer, H., van den Bosch, W., & Miller. A. (2012). Review: Dialectical behaviour
therapy with adolescents. Child and Adolescent Mental Health, 17(2), 65-75.
Harned, M. S., Korslund, K. E., Foa, E. B., & Linehan, M. M. (2012). Treating PTSD in suicidal

41

and self-injuring women with borderline personality disorder: Development and
preliminary evaluation of a Dialectical Behavior Therapy Prolonged Exposure
protocol. Behaviour Research and Therapy, 50, 381-386.
Hayes, S. C., Wilson, K. G., Gifford, E. V., Follette, V. M., & Strosahl, K. (1996). Experiential
avoidance and behavioral disorders: A functional dimensional approach to diagnosis and
treatment. Journal of Consulting and Clinical Psychology, 64(6), 1152.
Heimberg, R. G., Horner, K. j., Juster, H. r., Safren, S. A., Brown, E. J., Schneier, F. R., &
Liebowitz, M. R. (1999). Psychometric properties of the Liebowitz Social Anxiety Scale.
Psychological Medicine, 29, 199-212.
Hulbert, C., & Thomas, R. (2010). Predicting self-injury in BPD: an investigation of the
experiential avoidance model. Journal of Personality Disorders, 24(5), 651-663.
James, A. C., Taylor, A., Winmill, L., & Alfoadari, K. (2008). A preliminary community study
of Dialectical Behavior Therapy (DBT) with adolescent females demonstrating persistent,
deliberate self-harm (DSH). Child and Adolescent Mental Health, 13, 148-152.
Jacobson, N. S., Follette, W. C., & Revenstorf, D. (1984). Psychotherapy outcome research:
Methods for reporting variability and evaluating clinical significance. Behavior Therapy,
15, 336-352.
Jones, A. (2004). Involving children and young people as a researcher. In Doing research with
children and young people, ed. S. Fraser, V. Lewis, S. Ding, M. Kellett, and C. Robinson,
113–30. London: Routledge.
Joormann, J., & Gotlib, I. H. (2010). Emotion Regulation in Depression: Relation to Cognitive
Inhibition. Cognition & Emotion, 24(2), 281–298.
Kaess, M., Brunner, R., & Chanen, A. (2014). Borderline personality disorder in adolescence.

42

Pediatrics, 134(4), 782-793.
Kashdan, T. B., Barrios, V., Forsyth, J. P., & Steger, M. F. (2006). Experiential avoidance as a
generalized psychological vulnerability: Comparisons with coping and emotion
regulation strategies. Behaviour Research and Therapy, 44(9), 1301-1320.
Katz, L. Y., & Cox, B. J. (2002). Dialectical Behavior Therapy for suicidal adolescent inpatients:
A case study. Clinical Case Studies, 1(1), 81-92.
Keshen, A., Helson, T., Town, J., & Warren, K. (2017). Self-efficacy as a predictor of treatment
outcome in an outpatient eating disorder program. Eating Disorders, 25(5), 406-419.
Koons, C. R., Robins, C. J., Tweed, J. L., Lynch, T. R., Gonzalez, A. M., Morse, J. Q., . .
. Bastian, L. A. (2001). Efficacy of dialectical behavior therapy in women veterans with
borderline personality disorder. Behavior Therapy, 32(2), 371-390.
Kopala-Sibley, D. C., Zuroff, D. C., Russell, J. J., Moskowitz, D. S., & Paris, J. (2012).
Understanding heterogeneity in borderline personality disorder: Differences in affective
reactivity explained by the traits of dependency and self-criticism. Journal of Abnormal
Psychology, 121(3), 680-691.
Kröger, C., Harbeck, S., Armbrust, M., & Kliem, S. (2013). Effectiveness, response, and
dropout of dialectical behavior therapy for borderline personality disorder in an inpatient
setting. Behaviour Research and Therapy, 51(8), 411-416.
Landes, S. J., Chalker, S. A., & Comtois, K. A. (2016). Predicting dropout in outpatient
dialectical behavior therapy with patients with borderline personality disorder receiving
psychiatric disability. Borderline Personality Disorder and Emotion Dysregulation, 3, 9.
Lang, C. M., & Sharma-Patel, K. (2011). The relation between childhood maltreatment and self-

43

injury: A review of the literature on conceptualization and intervention. Trauma,
Violence, & Abuse, 12(1), 23-37.
Leary, M. R. (1983). A brief version of the Fear of Negative Evaluation Scale. Personality and
Social Psychology Bulletin, 9, 371-375.
Leon, A., Davis, L., & Kraemer, H. (2011). The role and interpretation of pilot studies in clinical
research. Journal of Psychiatric Research., 45(5), 626.
Leon, A. C., Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997). Assessing psychiatric
impairment in primary care with the Sheehan Disability Scale. The international journal
of psychiatry in medicine, 27(2), 93-105.
Linehan M. M. (1993a). Cognitive-Behavioral Treatment of Borderline Personality Disorder.
New York: Guilford.
Linehan M. M. (1993b). Skills Training Manual for Treating Borderline Personality Disorder.
New York: Guilford.
Linehan, M. (2014). DBT® skills training manual. Guilford Publications.
Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., ...
Lindenboim, N. (2006). Two-year randomized controlled trial and follow-up of
dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline
personality disorder. Archives of General Psychiatry, 63(7), 757-766.
Linehan, M. M., Dimeff, L., Koerner, K., & Miga, E. M. (2014). Research on dialectical
behavior therapy: Summary of the data to date. Retrieved from http://behavioraltech.org/
downloads/Research-on-DBT_Summary-of-Data-to-Date.pdf
Linehan, M. M., Dimeff, L. A., Reynolds, S. K., Comtois, K. A., Welch, S. S., Heagerty,

44

P., & Kivlahan, D. R. (2002). Dialectical behavior therapy versus comprehensive
validation therapy plus 12-step for the treatment of opioid dependent women meeting
criteria for borderline personality disorder. Drug & Alcohol Dependence, 67(1), 13-26.
Linehan, M. M., Schmidt, H., Dimeff, L. A., Craft, J. C., Kanter, J., & Comtois, K. A.
(1999). Dialectical behavior therapy for patients with borderline personality disorder and
drug‐dependence. The American Journal on Addictions, 8(4), 279-292.
Linehan, M. M., Suarez, A., & Allmon, D. (1991). Cognitive-Behavioral Treatment of
Chronically. Archive of General Psychiatry, 48, 1060-1064.
Lynch, T. R., Gray, K. L., Hempel, R. J., Titley, M., Chen, E. Y., & O’Mahen, H. A. (2013).
Radically open-dialectical behavior therapy for adult anorexia nervosa: Feasibility and
outcomes from an inpatient program. BMC Psychiatry, 13(1), 293.
Lynch, T. R., Trost, W. T., Salsman, N., & Linehan, M. M. (2007). Dialectical behavior therapy
for borderline personality disorder. Annual Review of Clinical Psychology, 3, 181-205.
MacPherson, H. A., Cheavens, J. S., & Fristad, M. A. (2013). Dialectical Behavior Therapy for
adolescents: Theory, treatment adaptations, and empirical outcomes. Clinical Child and
Family Psychology Review, 16(1), 59-80.
Mahoney, A. E., & McEvoy, P. M. (2012). A transdiagnostic examination of intolerance of
uncertainty across anxiety and depressive disorders. Cognitive Behaviour Therapy, 41(3),
212-222.
Masia-Warner, C., Storch, E. A., Pincus, D. B., Klein, R. G., Heimberg, R. G., & Liebowitz, M.
R. (2003). The Liebowitz social anxiety scale for children and adolescents: an initial
psychometric investigation. Journal of the American Academy of Child & Adolescent
Psychiatry, 42(9), 1076-1084.

45

McCredie, M. N., Quinn, C. A., & Covington, M. (2017). Dialectical behavior therapy in
adolescent residential treatment: Outcomes and effectiveness. Residential Treatment for
Children & Youth, 34(2), 84-106.
McDonell, M. G., Tarantino, J., Dubose, A. P., Matestic, P., Steinmetz, K., Galbreath, H., &
McClellan J. M. (2010). A pilot evaluation of dialectical behavioural therapy in
adolescent long-term inpatient care. Child and Adolescent Mental Health, 15(4), 193-196
McEvoy, P., & Mahoney, A. (2012). To Be Sure, To Be Sure: Intolerance of uncertainty
mediates symptoms of various anxiety disorders and depression. Behavior Therapy,
43(3), 533-545.
McHugh, R. K., & Barlow, D. H. (2010). The dissemination and implementation of evidencebased psychological treatments: a review of current efforts. American Psychologist,
65(2), 73.
McKenzie, K. C., & Gross, J. J. (2014). Nonsuicidal self-injury: An emotion regulation
perspective. Psychopathology, 47(4), 207-219.
McMain, S. F., Fitzpatrick, S., Boritz, T., Barnhart, R., Links, P., & Streiner, D. L. (2017).
Outcome trajectories and prognostic factors for suicide and self-harm behaviors in
patients with borderline personality disorder following one year of outpatient
psychotherapy. Journal of Personality Disorders, 1-16.
McMain, S. F., Links, P. S., Gnam, W. H., Guimond, T., Cardish, R. J., Korman, L., & Streiner,
D. L. (2009). A randomized trial of dialectical behavior therapy versus general
psychiatric management for borderline personality disorder. American Journal of
Psychiatry, 166(12), 1365-1374.
Memel, B. (2012). A quality improvement project to decrease the length of stay on a psychiatric

46

adolescent partial hospital program. Journal of Child and Adolescent Psychiatric
Nursing, 4, 207-218.
Mennin, D. S., Heimberg, R. G., Turk, C. L., & Fresco, D. M. (2002). Applying an emotion
regulation framework to integrative approaches to generalized anxiety disorder. Clinical
Psychology: Science and Practice, 9(1), 85-90.
Miller, A. L. (1999). Dialectical Behavior Therapy: A new treatment approach for suicidal
adolescents. American Journal of Psychotherapy, 53, 413-417.
Miller, A. L., Muehlenkamp, J. J., & Jacobson, C. M. (2008). Fact or fiction: Diagnosing
borderline personality disorder in adolescents. Clinical Psychology Review, 28(6), 969981.
Miller, A. L., Rathus, J. H., Linehan, M. M. Wetzler, S., & Leigh, E. (1997). Dialectical
Behavior Therapy adapted for suicidal adolescents. Journal of Practical Psychiatry and
Behavioral Health, 3, 78-86.
Neacsiu, A. D., Eberle, J. W., Kramer, R., Wiesmann, T., & Linehan, M. M. (2014). Dialectical
behavior therapy skills for transdiagnostic emotion dysregulation: A pilot randomized
controlled trial. Behaviour Research and Therapy, 59, 40-51.
Neumann, A., van Lier, P. A. C., Gratz, K. L., & Koot, H. M. (2010). Multidimensional
assessment of emotion regulation difficulties in adolescents using the difficulties in
emotion regulation scale. Assessment, 17(1), 138-149.
Nock, M.K., Borges, G., Bromet, E., Cha, C.B., Kessler, R.C., & Lee, S. (2008). Suicide and
suicidal behavior. Epidemiologic Reviews, 30, 133–154.
Pagura, J., Stein, M. B., Bolton, J. M., Cox, B.J., Grant, B., & Sareen, J. (2010). Comorbidity of

47

borderline personality disorder and posttraumatic stress disorder in the U.S. population.
Journal of Psychiatric Research, 44, 1190–1198.
Palmer, R. L., Birchall, H., Damani, S., Gatward, N., McGrain, L., & Parker, L. (2003). A
dialectical behavior therapy program for people with an eating disorder and borderline
personality disorder -- description and outcome. International Journal of Eating
Disorders, 33(3), 281-286.
Panos, P. T., Jackson, J. W., Hasan, O., & Panos, A. (2014). Meta-analysis and systematic
review assessing the efficacy of dialectical behavior therapy (DBT). Research on Social
Work Practice, 24(2), 213-223.
Perez, J., Venta, A., Garnaat, C. S. (2012). The Difficulties in Emotion Regulation Scale: Factor
structure and association with nonsuicidal self-injury in adolescent inpatients. Journal of
Psychopathol Behav Assess, 34, 393-404.
Perroud, N., Uher, R., Dieben, K., Nicastro, R., & Huguelet, P. (2010). Predictors of response
and drop-out during intensive dialectical behavior therapy. Journal of Personality
Disorders, 24, 634-650.
Rathus, J. H., & Miller, A. L. (2000). DBT for adolescents: Dialectical dilemmas and secondary
treatment targets. Cognitive and Behavioral Practice, 7, 425-434.
Rathus, J. H., & Miller, A. L. (2002). Dialectical Behavior Therapy adapted for suicidal
adolescents. Suicide Life Threatening Behaviors, 32, 146-157.
Raymond, C. (1983). "The clinical use of difference scores: Some psychometric problems."
Multivariate Experimental Clinical Research, 6(2), 87.
Ritschel, L., Lim, N. E., & Stewart, L. M. (2015). Transdiagnostic applications of DBT for
adolescents and adults. American Journal of Psychotherapy, 69(2), 111-128.

48

Rizvi, S. L. (2011). Treatment failure in dialectical behavior therapy. Cognitive and Behavioral
Practice, 18, 403-412.
Robins, C. J., & Chapman, A. L. (2004). Dialectical Behavior Therapy: Current status, recent
developments, and future directions. Journal of Personality Disorders, 18(1), 73-89.
Rogosa, D. W., & Willett, J. B. (1983). Demonstrating the reliability of the difference score in
the measurement of change. Journal of Education Measurement, 20, 335–343.
Rosenthal, M. Z., Hall, M. L. R., Palm, K. M., Batten, S. V., & Follette, V. M. (2005). Chronic
avoidance helps explain the relationship between severity of childhood sexual abuse and
psychological distress in adulthood. Journal of Child Sexual Abuse, 14(4), 25-41.
Ruggiero, K. J., Del Ben, K., Scotti, J. R., & Rabalais, A. E. (2003). Psychometric properties of
the PTSD Checklist—Civilian version. Journal of Traumatic Stress, 16(5), 495-502.
Rüsch, N., Schiel, S., Corrigan, P., Leihener, F., Jacob, G., Olschewski, M., . . . Bohus,
M. (2008). Predictors of dropout from inpatient dialectical behavior therapy among
women with borderline personality disorder. Journal of Behavior Therapy and
Experimental Psychiatry, 39(4), 497-503.
Rush, A. J., Trivedi, M., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., . . . Keller, M.
B. (2003). The 16-item quick inventory of depressive symptomatology (QIDS), clinician
rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with
chronic major depression. Biological Psychiatry, 54(5), 573-583.
Safer, D. L., Telch, C. F., & Agras, W. S. (2001). Dialectical behavior therapy for bulimia
nervosa. American Journal of Psychiatry, 158(4), 632-634.
Schneider W. H. The establishment of Institutional Review Boards in the U.S. background

49

history. [Last accessed on 2019 June 10]. Available from: http://www.iupui.edu/
~histwhs/ G504.dir/irbhist.html.
Sheehan , D. V. ( 1986 ). The anxiety disease . New York: Bantam. Leon , A. C., Olfson , M.,
Portera , L., Farber , L., & Sheehan , D. V. (1997). Assessing psychiatric impairment in
primary care with the Sheehan Disability Scale. International Journal of Psychiatry in
Medicine, 27, 93 – 105.
Sheehan , K. H. , & Sheehan , D. V. ( 2008 ). Assessing treatment effects in clinical trials with
the discan metric of the Sheehan Disability Scale. International Clinical
Psychopharmacology, 23, 70 – 83.
Shore, N., Brazauskas, R., Drew, E., Wong, K. A., Moy, L., Baden, A. C., . . . Seifer, S. D.
(2011). Understanding community-based processes for research ethics review: A national
study. American Journal of Public Health, 101, S359-S364.
Soler, J., Trujols, J., Pascual, J. C., Portella, M. J., Barrachina, J., Campins, J., ... & Pérez, V.
(2008). Stages of change in dialectical behaviour therapy for borderline personality
disorder. British Journal of Clinical Psychology, 47(4), 417-426.
Stangier, U., Heidenreich, T., Peitz, M., Lauterbach, W., & Clark, D. M. (2003). Cognitive
therapy for social phobia: individual versus group treatment. Behaviour Research and
Therapy, 41(9), 991-1007.
Steil, R., Dyer, A., Priebe, K., Kleindienst, N., & Bohus, M. (2011). Dialectical behavior therapy
for posttraumatic stress disorder related to childhood sexual abuse: a pilot study of an
intensive residential treatment program. Journal of Traumatic Stress, 24(1), 102-106.
Sternheim, L., Startup, H., & Schmidt, U. (2011). An experimental exploration of behavioral and

50

cognitive–emotional aspects of intolerance of uncertainty in eating disorder patients.
Journal of Anxiety Disorders, 25(6), 806-812.
Steuwe, C., Berg, M., Driessen, M., & Beblo, T. (2017). Impact of therapist change after initial
contact and traumatic burden on dropout in a naturalistic sample of inpatients with
borderline pathology receiving dialectical behavior therapy. Borderline Personality
Disorder and Emotion Dysregulation 4, 14.
Swenson, C. R., Sanderson, C., Dulit, R., & Linehan, M. M. (2001). The application of
Dialectical Behavior Therapy for patients with borderline personality disorder on
inpatient units. Psychiatric Quarterly, 72(4), 307-324.
Telch, C. F., Agras, W. S., & Linehan, M. M. (2001). Dialectical behavior therapy for binge
eating disorder. Journal of Consulting and Clinical Psychology, 69(6), 1061-1074.
Thompson, R. A. (1994). Emotion regulation: A theme in search of definition. Society for
Research in Child Development, 59(2), 25-52.
Thompson, B. L., & Waltz, J. (2010). Mindfulness and experiential avoidance as predictors of
posttraumatic stress disorder avoidance symptom severity. Journal of Anxiety Disorders,
24(4), 409-415.
Tull, M. T., Barrett, H. M., McMillan, E. S., & Roemer, L. (2007). A preliminary investigation
of the relationship between emotion regulation difficulties and posttraumatic stress
symptoms. Behavior Therapy, 38(3), 303-313.
Twenge, J. M., Joiner, T. E., Rogers, M. L., & Martin, G. N. (2018). Increases in depressive
symptoms, suicide-related outcomes, and suicide rates among US adolescents after 2010
and links to increased new media screen time. Clinical Psychological Science, 6(1), 3-17.
Verheul, R., Van Den Bosch, L. M., Koeter, M. W., De Ridder, M. A., Stijnen, T., & Van

51

Den Brink, W. (2003). Dialectical behaviour therapy for women with borderline
personality disorder: 12-month, randomised clinical trial in The Netherlands. The British
Journal of Psychiatry, 182(2), 135-140.
Vitiello, B. (2003). Ethical considerations in psychopharmacological research involving children
and adolescents. Psychopharmacology, 171(1), 86–91.
Wasser, T., Tyler. R., McIlhaney, K., Taplin, R., & Henderson, L. (2008). Effectiveness of
dialectical behavior therapy (DBT) versus standard therapeutic milieu (STM) in a cohort
of adolescents receiving residential treatment. Best Practices in Mental Health, 4(2), 114125.
Weinberg, A., & Klonsky, E. D. (2009). Measurement of emotion dysregulation in adolescents.
Psychological Assessment, 21(4), 616-621.
Whiteside, S. P. (2009). Adapting the Sheehan Disability Scale to assess child and parent
impairment related to childhood anxiety disorders. Journal of Clinical Child &
Adolescent Psychology, 38(5), 721-730.
Whittaker, J. K., Holmes, L., del Valle, J. F., Ainsworth, F., Andreassen, T., Anglin, J., . . .
Courtney, M. (2016). Therapeutic residential care for children and youth: A consensus
statement of the international work group on therapeutic residential care. Residential
Treatment for Children & Youth, 33(2), 89-106.
Wilhelm, S., & Steketee, G. S. (2006). Cognitive therapy for obsessive compulsive disorder: A
guide for professionals. New Harbinger Publications.
Williams, R. H., & Zimmerman, D. W. (1996). Are simple gain scores obsolete? Applied
Psychological Measurement, 20(1), 59-69.
Woodberry, K. A., & Popenoe, E. J. (2008). Implementing Dialectical Behavior Therapy with

52

adolescents and their families in a community outpatient clinic. Cognitive and Behavioral
Practice, 34, 15–25.
Wright, K., Lebell, M., & Carleton, R. (2016). Intolerance of uncertainty, anxiety sensitivity,
health anxiety, and anxiety disorder symptoms in youth. Journal of Anxiety Disorders.,
41, 35-42.
Yook, K., Kim, K. H., Suh, S. Y., & Lee, K. S. (2010). Intolerance of uncertainty, worry, and
rumination in major depressive disorder and generalized anxiety disorder. Journal of
Anxiety Disorders, 24(6), 623-628.

53

Appendix
Table 1. Means and standard deviations of study measures.
Predictor Variables
Pre
Post
Mean
SD
Mean
DERS
Nonacceptance
19.91
6.05
12.21
Goals
19.72
4.19
13.94
Impulse
17.31
5.97
9.57
Aware
20.61
4.74
13.64
Strategies
28.83
6.89
16.81
Clarity
16.85
4.23
11.51
Total
123.48
21.56
77.45
BFNE
Total
39.07
5.20
30.25
PCL-5
Total
43.62
18.09
21.33
IUSC
Total
86.09
20.20
63.73
AAQ-II
Total
19.27
7.53
37.17
Outcome Measures

Pre
Mean

BSL-23
Total
QIDS
Total
PQ-LES-Q
Total

SD
5.24
5.32
3.6
5.55
7.4
4.07
26.38
4.57
13.80
22.00
9.37

Post
SD

Mean

SD

2.18

0.85

1.03

0.81

16.57

4.59

7.91

5.02

45.93

14.24

68.86

15.59

Note. DERS = Difficulty of Emotions Regulation Scale; BFNE =
Brief Fear of Negative Evaluation Scale; PCL-5 = PTSD
Checklist for DSM-5; IUSC = Intolerance of Uncertainty Scale for
Children; AAQ-II = Acceptance and Action Questionnaire-II;
BSL-23 = Borderline Symptom List; QIDS = Quick Inventory of
Depressive Symptomatology; PQ-LES-Q = Pediatric Quality of
Life Enjoyment and Satisfaction Questionnaire.
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Table 2. Independent linear regression analyses with BSL-23, QIDS, and PQ-LES-Q
residual change scores regressed onto predictor variables.
Measures
F
b
t
R2
p
DV = BSL-23 residualized
change scores.
DERS-36 Total
F(1, 89) = .01
0.01
0.09
< .01
0.93
BFNE Total

F(1, 9) = .01

-0.02

-0.07

< .01

0.95

PCL-5 Total

F(1, 19) = .05

0.05

0.23

< .01

0.82

AAQ-II Total

F(1, 5) = 2.89

0.61

1.70

0.37

0.15

IUSC Total
DV = QIDS residualized
change scores.

F(1, 89) = 2.98

0.18

1.73

0.03

0.09

DERS-36 Total

F(1, 89) = .72

-0.09

-0.85

< .01

0.40

BFNE Total

F(1, 9) = .20

0.15

0.45

0.02

0.66

PCL-5 Total

F(1, 19) = .01

0.02

0.08

< .01

0.94

AAQ-II Total

F(1, 5) = 1.37

0.46

1.17

0.22

0.30

IUSC Total
DV = PQ-LES-Q
residualized change scores.

F(1, 89) = .97

0.12

1.16

0.02

0.25

DERS-36 Total

F(1, 89) = 1.19

0.12

1.09

0.01

0.28

BFNE Total

F(1, 9) = .82

0.29

0.91

0.08

0.39

PCL-5 Total

F(1, 19) = .13

0.08

0.36

< .01

0.72

AAQ-II Total

F(1, 5) = 2.28

-0.56

-1.51

0.31

0.19

IUSC Total

F(1, 89) = 1.88

-0.14

-0.137

0.02

0.17

Note. DERS-36 = Difficutlies in Emotion Regulation Scale; BFNE = Brief Fear of
Negative Events Scale; PCL-5 = PTSD Checklist for DSM-5; IUSC = Intolerance of
Uncertainty Scale for Children; AAQ-II = Acceptance and Action Questionnaire-II; BSL23 = Borderline Symptom List; QIDS = Quick Inventory of Depressive Symptomatology;
PQ-LES-Q = Pediatric Quality of LIfe Enjoyment and Satisfaction Questionnaire.
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Table 3. RC, RCI, and CSC status for each resident. Total represents the sum of absolute values.
RCI
RCI
CSC
RC
Yes = 1
CSC
RC
Yes = 1
Yes = 1
Yes = 1
No = 0
Yes = 1
Yes = 1
No = 0
No = 0
ID
No = 0
Decline = -1
No = 0
ID
No = 0
Decline = -1
Decline = -1
50
1
1
0
1
1
1
0
2
1
-1
-1
51
0
0
0
3
1
1
0
52
1
1
0
4
0
0
0
53
1
1
0
5
0
0
0
54
1
1
1
6
0
0
0
55
1
1
0
7
1
-1
0
56
0
0
0
8
0
0
0
57
1
1
1
9
0
0
0
59
1
1
0
10
1
1
0
60
1
1
1
11
0
0
0
61
0
0
0
12
0
0
0
62
1
1
0
13
1
1
0
64
1
1
0
14
1
1
0
65
0
0
0
15
0
0
0
67
0
0
0
16
1
1
0
68
1
1
0
17
1
1
0
69
1
1
1
18
0
0
0
70
1
1
1
19
1
1
1
72
0
0
0
21
1
1
0
73
0
0
0
22
0
0
0
74
1
1
1
23
0
0
0
75
1
1
0
24
0
0
0
76
1
1
0
25
1
1
0
77
1
1
1
26
1
1
0
79
0
0
0
27
1
1
0
80
1
1
0
28
0
0
0
81
1
1
1
29
0
0
0
82
0
0
0
30
1
1
0
83
0
0
0
31
0
0
0
84
1
1
1
32
0
0
0
85
1
1
1
33
1
1
0
86
0
0
0
34
1
1
1
87
1
1
1
35
1
1
1
88
0
0
0
36
1
1
0
89
0
0
0
37
0
0
0
90
1
1
1
38
1
1
1
91
1
-1
0
40
1
1
1
92
0
0
0
42
0
0
0
93
1
1
0
43
1
1
0
94
0
0
0
44
1
1
1
95
1
1
1
45
0
0
0
96
0
0
0
46
0
0
0
98
1
1
0
47
1
1
0
99
1
1
1
48
0
0
0
100
0
0
0
49
1
1
1
104
1
1
1
RC = 54, No RC = 38; RCI = 51, No RCI = 38, Deteriorated = 3; CSC = 22, No CSC = 67, Deteriorated = 3.

Note . RC = reliable change; No RC = no reliable change. RCI = met relaible change index threshold for
improvement; No RCI = did not meet reliable change index threshold for improvement; Deteriorated = met
relabile change index threshold for deteriroation.
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Table 4. Means and standard deviations of pre and post scores of residents who showed CSC, No CSC, or Deterioration.
Clinically Significant Change
No Clinically Significant Change
Deteriorated
Measures
(n = 22)
(n = 67)
(n = 3)
Pre
Post
Pre
Pre
Pre
Post
Mean
SD
Mean
SD
Mean
SD
Mean
SD
Mean
SD
Mean
SD
BSL-23 (n = 92)
Total
52.23 12.05
6.55
3.02
47.94 21.08 27.45 16.40
39.00
3.00
67.67 15.28
QIDS (n = 92)
Total

16.41

4.17

3.59

1.56

16.27

4.86

8.94

4.67

18.50

0.71

18.00

4.58

PQ-LES-Q (n = 92)
Total

45.83

15.49

84.58

8.17

46.51

14.39

65.06

13.19

43.75

3.79

41.67

11.89

DERS-36 (n = 92)
Nonacceptance
Goals
Impulse
Awareness
Strategies
Clarity
Total

20.27
19.64
18.14
21.82
29.50
17.00
126.36

4.88
4.38
6.95
5.15
4.74
3.19
16.96

7.77
9.23
6.41
8.68
10.14
7.23
49.45

1.85
4.28
0.59
2.27
2.05
1.77
8.91

19.88
19.31
16.33
20.30
28.01
16.55
120.39

6.46
4.25
5.25
4.44
7.50
4.34
21.52

13.18
15.09
10.27
14.93
18.27
12.64
84.37

4.70
4.80
3.49
8.68
6.78
3.70
22.74

20.00
19.33
22.33
18.00
31.00
15.67
126.33

2.00
1.16
2.31
2.65
2.65
1.15
10.02

23.67
20.00
16.00
20.00
33.00
16.00
128.67

6.51
1.73
2.00
4.36
3.00
2.65
2.52

BFNE (n = 7)
Total

39.25

3.59

31.00

1.41

38.57

6.21

23.00

1.41

-

-

-

-

PCL-5 (n = 21)
Total

46.88

12.62

12.45

9.10

40.23

21.54

26.94

11.93

-

-

-

-

AAQ-II (n = 7)
Total

16.33

8.33

45.00

3.16

23.25

8.66

33.25

9.00

-

-

-

-

IUSC (n = 91)
Total
83.64 15.50 43.86 9.68
85.91 21.18 68.52 21.07
79.50 17.68 91.00 12.53
Note. CSC = clinically significant change; No CSC = no clinically signficiant change; Deterioration = clinically significant change
toward deterioration; DERS-36 = Difficutlies in Emotion Regulation Scale; BFNE = Brief Fear of Negative Events Scale; PCL-5 =
PTSD Checklist for DSM-5; IUSC = Intolerance of Uncertainty Scale for Children; AAQ-II = Acceptance and Action QuestionnaireII; BSL-23 = Borderline Symptom List; QIDS = Quick Inventory of Depressive Symptomatology; PQ-LES-Q = Pediatric Quality of
LIfe Enjoyment and Satisfaction Questionnaire.
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Table 5. Independent binary logistic regression with CSC group classification as the criterion variable
(CSC, No CSC), and pre-treatment scores of clinical measures as the predictor variable.
Cox & Nagelker
Measures
DERS (n = 92)
Total

B

SE

Wald

p

Exp(B)

Snell R 2

ke R 2

0.01

0.01

1.33

0.25

1.01

0.02

0.02

0.05

0.07

DERS (n = 92)
Nonacceptance
Goals
Impulse
Awareness
Strategies
Clarity

<.01
-0.07
0.06
0.10
0.03
-0.05

0.05
0.08
0.06
0.06
0.06
0.08

<.01
0.64
1.31
2.58
0.29
0.37

0.99
0.42
0.25
0.11
0.59
0.45

1.00
0.94
1.07
1.11
1.03
0.95

BFNE (n = 7)
Total

0.03

0.13

0.05

0.83

1.03

<.01

0.01

PCL-5 (n = 8)
Total

0.02

0.03

0.65

0.42

1.02

0.03

0.04

AAQ-II (n = 4)
Total

-0.13

0.12

1.10

0.29

0.88

0.18

0.24

IUSC (n = 91)
Total
-0.01
0.01
0.19
0.66
1.00
<.01
<.01
Note. CSC = clinically significant change; No CSC = no clinically signficiant change; Deterioration =
clinically significant change toward deterioration; DERS-36 = Difficutlies in Emotion Regulation
Scale; BFNE = Brief Fear of Negative Events Scale; PCL-5 = PTSD Checklist for DSM-5; IUSC =
Intolerance of Uncertainty Scale for Children; AAQ-II = Acceptance and Action Questionnaire-II.
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Supervisors: Bonnie Klein-Tasman, PhD, and Kristin Smith, PhD
Responsibilities: Led class discussions for first year clinical students that
included topics related to clinical interviewing, psychodiagnostic and
psychoeducational assessment, non-specific factors, and multicultural
considerations. Conducted live observation of first year clinical students
who administered assessments to student volunteers. Completed student
evaluations and provided end-of-year feedback ratings.

2016-2019

Extern/Advanced Practicum Student
Center for Behavioral Medicine, Brookfield, WI
DBT®- Linehan Board Certified Program
Clinical Supervisor: Kim Skerven, PhD
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The Center for Behavioral Medicine is an outpatient clinic that conducts
comprehensive DBT for adults and adolescents with borderline personality
disorder. The center is a Linehan-board certified DBT clinic and Kim
Skerven, my supervisor, is a Linehan-board certified DBT clinician.
Responsibilities: Conducted comprehensive Dialectical Behavior Therapy
with adults and adolescents, co-facilitated DBT skills groups, co-facilitated
family-skills training, administered psychodiagnostic assessments using
the Structured Clinical Interview for DSM-5 (SCID-5) and Montreal
Cognitive Assessment (MoCA), managed the program-outcomes database,
and presented independent research at national conferences.
2017-2018

Student Therapist Supervisor
University of Wisconsin-Milwaukee, Milwaukee, WI
UWM Psychology Clinic
Supervisors: Stacey Nye, PhD, and Robyn Ridley, PhD
Responsibilities: Led group discussions, conducted case
conceptualizations, provided feedback to therapists, and supervised two
graduate student therapy cases.

2015-2018

Graduate Student Therapist
University of Wisconsin-Milwaukee, Milwaukee, WI
UWM Psychology Clinic
Supervisors: Christopher Martell, PhD (2015-2016), Robyn Ridley, PhD
(2015-2018), and Shawn Cahill, PhD, (2016-2017)
Responsibilities: Conducted individual therapy with clients from the
university and the surrounding community using empirically supported
treatments that included cognitive behavioral interventions (e.g.,
Behavioral Activation, cognitive therapy, exposure therapy).

2014-2015

Assessment Practicum Student
University of Wisconsin-Milwaukee, Milwaukee, WI
UWM Psychology Clinic
Supervisors: Kristin Smith, PhD. and Han-joo Lee, PhD
Responsibilities: Administered psychodiagnostic and psychoeducational
assessments using instrumented that included the Wechsler Adult
Intelligence Scale 4th Edition (WAIS-IV), Wechsler Achievement Test 3rd
Edition (WIAT-III), Wechsler Intelligence Scale for Children 4th Edition
(WISC-4), Woodcock Johnson 3rd Edition (WJ-3), California Verbal Learning
Test 2nd Edition (CVLT-2), Delis-Kaplan Executive Function System (DKEFS), Minnesota Multiphasic Personality Inventory 2nd Edition (MMPI-2),
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Personality Assessment Inventory (PAI), Conners Continuous Performance
Test 3rd Edition (CPT-3). Completed scoring of all measures, interpretation
and write up of results and provided feedback.
RESEARCH EXPERIENCE
2013-2019

Graduate Research Assistant
University of Wisconsin-Milwaukee, Milwaukee, WI
Anxiety Disorders Laboratory
Department of Psychology
Principal Investigator: Han-joo Lee, PhD
Responsibilities: Development and execution of independent research
projects, database management and analysis, manuscript and conference
preparations, attended weekly supervision meetings, and supervised and
trained undergraduate research assistants. Independent evaluator on
three randomized controlled studies:
1. Attention training for individuals with social anxiety: administered
the Mini International Neuropsychiatric Interview (MINI)
2. Inhibition control for children with trichotillomania: administered
the Trichotillomania Scale for Children (TSC)
3. Inhibition control for adults with OCD and Obsessive-Compulsive
Related Disorders (OCRDs): administered the Yale-Brown
Obsessive-Compulsive Scale (Y-BOCS) and the Anxiety Disorder
Interview Schedule (ADIS-IV)

2012

Undergraduate Research Assistant
Yale University, New Haven, CT
Yale Depression and Cognition Program
Department of Psychology
Principal Investigator: Susan Nolen-Hoeksema, PhD
Responsibilities: Assisted with data management, participant recruitment,
attended didactic seminars, and presented an oral presentation of a
capstone research project examining the effects of perceived stress on
rumination among ethnically diverse adolescent females.

2012

Undergraduate Research Assistant
Yale University, New Haven, CT
Dialectical Behavior Therapy Program
Department of Psychiatry
Principal Investigator: Seth Axelrod, PhD
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Responsibilities: Transcribed Dialectical Behavior Therapy (DBT) sessions
from the National Education Alliance for Borderline Personality Disorder
(NEA-DBT) conference held in April 2011.
2011-2013

Undergraduate Research Assistant
University of California-San Diego, San Diego, CA
Skills Training and Empowerment Program (STEP)
Department of Psychiatry
Principal Investigator: Brent Mausbach, PhD
Responsibilities: Co-led a psychosocial intervention for individuals with
schizophrenia and schizoaffective disorder, assisted with data
management, participant recruitment, prepared conference
presentations, conducted literature searches, co-authored peer-reviewed
manuscripts and an unpublished treatment manual, was and independent
evaluator for a NIMH-R01 randomized controlled trial for older adults with
schizophrenia and schizoaffective disorder. Certified to administer the
Positive and Negative Syndrome Scale (PANSS), University of California,
San Diego Performance-based Skills Assessment (UPSA), and the
Repeatable Battery for the Assessment of Neuropsychological Status
(RBANS).

2011

Undergraduate Research Assistant
San Diego State University, San Diego, CA
Intergroup Relations Laboratory
Department of Psychology
Principal Investigator: Thierry Devos, PhD
Responsibilities: Assisted with data collection and management,
participated in lab meetings, provided feedback on lab presentations,
contributed to group discussions, and conducted literature reviews.
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anxiety? Poster presented at the 2014 UWM undergraduate research symposium,
Milwaukee, WI.
Davine, T., Turkel, J. E., Siwiec, S. G., Goetz, A. R., Spencer, S., & Lee, H-J. (2014). Evaluating the
relevance of ‘not just right’ experiences for specific symptom domains of OCD. Poster
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presented at the University of Wisconsin-Milwaukee Undergraduate Research
Symposium, Milwaukee, WI.
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TEACHING EXPERIENCE
Spring 2017

Adjunct Instructor
Alverno College
Department of Psychology
Course: Experimental Psychology (Psy350)
Department Chair: Kim Skerven, PhD

Fall 2016

Adjunct Instructor
Mount Mary University
Department of Psychology
Course: Social Psychology (Psy256)
Department Chair: Laurel End, PhD

Spring 2014

Teaching Assistant
University of Wisconsin-Milwaukee
Department of Psychology
Course: Personality Psychology (Psych205)
Instructor: Molly O’Connor, MS

Fall 2013

Teaching Assistant
University of Wisconsin-Milwaukee
Department of Psychology
Course: Social Psychology (Psych230)
Instructor: Morgan Hodge, MS

Spring 2013

Teaching Assistant
San Diego State University
Department of Psychology
Course: Intermediate Statistics
Instructor: Charles Van Liew, MS
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11/27/17
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University of Wisconsin-Milwaukee
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Helen Bader School of Social Work
Topic: Overview of Dialectical Behavior Therapy (DBT)
2/4/15

Guest Lecturer
University of Wisconsin-Milwaukee
Department of Psychology
Course: Personality Psychology (Pych205)
Topic: Research Methods for Personality Psychology (Psych205)
Instructor: Kristin Smith, PhD
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Association for Behavioral and Cognitive Therapies (ABCT)
American Psychological Association (APA)
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